[go: up one dir, main page]

WO2005033304A1 - Immobilization element coated with functional-substance-containing thin film and process for producing the same - Google Patents

Immobilization element coated with functional-substance-containing thin film and process for producing the same Download PDF

Info

Publication number
WO2005033304A1
WO2005033304A1 PCT/JP2004/014055 JP2004014055W WO2005033304A1 WO 2005033304 A1 WO2005033304 A1 WO 2005033304A1 JP 2004014055 W JP2004014055 W JP 2004014055W WO 2005033304 A1 WO2005033304 A1 WO 2005033304A1
Authority
WO
WIPO (PCT)
Prior art keywords
porous
thin film
coated
immobilization
functional substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2004/014055
Other languages
French (fr)
Japanese (ja)
Inventor
Masaru Kato
Kumiko Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency filed Critical Japan Science and Technology Agency
Publication of WO2005033304A1 publication Critical patent/WO2005033304A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites

Definitions

  • the present invention relates to a fixing device covered with a functional substance-containing thin film and a method for producing the same. More specifically, the present invention relates to an immobilization device coated with a thin film containing a functional substance in a network structure in nanometer units, a porous immobilization device having pores in nanometer units, and The present invention relates to a method for forming a thin film on a fixed element.
  • a protein immobilization method widely used as a functional substance includes a carrier binding method in which a protein is bound to an insoluble carrier, and a crosslinking method in which an enzyme is reacted with a reagent having two or more functional groups.
  • Inclusion methods include wrapping in a fine gel lattice or covering with a semipermeable polymer film.
  • Non-Patent Document 1 there is a method of immobilizing trypsin using glutaraldehyde using aminoethylcellulose such as Glassmeyer and CK.
  • Patent Document 2 An immobilized enzyme preparation immobilized thereon (Patent Document 1) and a lipase complex immobilized on insoluble matrix (Patent Document 2) have been developed. Since the carrier binding method is an immobilization method using a covalent bond, the enzyme is not easily desorbed, but the reaction operation is complicated, relatively intense, and a protein that is a biologically active substance because of the treatment. However, there is a disadvantage that changes in the higher-order structure and a decrease in activity are likely to occur.
  • Non-patent document 3 immobilized lipase produced by binding a coupling agent having a carboxylic acid ester bond to an inorganic carrier (Patent Document 3), and a substrate substrate having a bioactive agent immobilized on an organic film A flat biomolecule screening device (Patent Document 4) and the like have been developed.
  • the cross-linking method is simpler than the carrier-binding method, it has a drawback that the activity tends to decrease because the bioactive substance is carried out through a covalent bond.
  • Non-Patent Document 3 Unlike the carrier binding method and the cross-linking method, this method does not require the biologically active substance to be bonded to the carrier, and thus has the advantage that the activity does not easily decrease. Since there is no binding reaction, the strength tends to be low! /
  • Non-Patent Document 4 a bioactive substance can be fixed and applied as a bioreactor while retaining the higher-order structure and biological activity. After the sol-gel reaction, the gel is dried and crushed according to various uses. When the activity of immobilized protein and the like was reduced, and the treatment process was complicated! /
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2000-83663
  • Patent Document 2 Japanese Patent Publication No. 2002-539782
  • Patent document 3 JP-A-9-313179
  • Patent Document 4 Japanese Patent Publication No. 2002-520621
  • Non-Patent Document l Glassmeyer, C.K.et.al, Biochemistry, 1971, 10, 786.
  • Non-Patent Document 2 Quiocho, F.A. et.al, Proc.Nat.Acad.Sci. 1964, 52, 833
  • Non-Patent Document 3 Bernfeld, P. et.al, Science, 142, 678, 1963
  • Non-patent document 4 Ellerby et.al, Science, 1992, 255, 1113-1115
  • the present invention can be used for screening drug candidates, for clinical tests, or for detecting changes in environmental factors, and can also be used as a bioreactor for functional substances, and is simple and inexpensive to manufacture. It is an object of the present invention to provide a functional substance-immobilizing element having a wide variety of usable physiologically active substances and a high functionality.
  • nm nanometers
  • a physiologically active substance such as a metabolic enzyme which is unstable and easily loses its activity outside the cell is included in the micronome, and a sol reaction solution containing the micronome and an organometallic compound having a hydrolyzable functional group is prepared.
  • a sol reaction solution containing the micronome and an organometallic compound having a hydrolyzable functional group is prepared.
  • the present inventors have proposed an organometallic compound having a hydrolyzable functional group under a specific condition. By treating under the above conditions, it is possible to produce a porous fixed element having a porous structure having a through hole of several Wm that is permeable to a solvent, and having pores of several nm in diameter on the surface of the structure. Obtained knowledge. The present invention has been completed based on these findings.
  • the present invention provides an immobilized element, particularly a porous immobilized element, which is covered with a thin film having a network structure containing a functional substance.
  • the immobilization element has a porous structure having a through-hole of 0.1-10 O / zm, which is permeable to a solvent, and has a diameter of 11-100 nm on the surface of the structure.
  • a fixing device which is a porous fixing device having pores and is coated with a thin film having a network structure containing a functional substance.
  • the functional substance is at least one selected from the group consisting of a physiologically active substance such as a protein, a nucleic acid, a lipid, a sugar, a drug, a metal catalyst, and a compound having a specific shape.
  • a physiologically active substance such as a protein, a nucleic acid, a lipid, a sugar, a drug, a metal catalyst, and a compound having a specific shape.
  • a coated immobilized element is provided.
  • the present invention also provides an immobilization element, particularly a porous immobilization element, which is covered with a network-like thin film containing microsomes containing a functional substance.
  • the present invention provides a porous immobilization element, wherein the immobilization element has a porous structure having several / zm through-holes permeable to a solvent and has pores having a diameter of several nm on the surface of the structure.
  • the present invention provides an immobilization element covered with a network-like thin film containing microsomes containing a functional substance.
  • the present invention provides an immobilization device, wherein the functional substance is coated with a thin film having a network structure including microsomes containing the functional substance, which is a metabolic enzyme such as P450 or Darc-transferase.
  • a metabolic enzyme such as P450 or Darc-transferase.
  • a dani element is provided.
  • the present invention provides a thin film having a network structure containing a functional substance, or a porous immobilization element covered with a thin film having a network structure containing microsomes containing a functional substance.
  • a column or microchip Provide a column or microchip.
  • the present invention is a method for coating a thin film having a network structure containing a functional substance on an immobilization element, comprising:
  • the present invention provides a porous immobilization film having a porous structure having a through hole of 0.1-10 O / zm that is permeable to a solvent, and having pores having a diameter of 11 lOO nm on the surface of the structure.
  • a porous immobilization film having a porous structure having a through hole of 0.1-10 O / zm that is permeable to a solvent, and having pores having a diameter of 11 lOO nm on the surface of the structure.
  • the present invention is a method for producing the porous immobilized element, comprising:
  • organometallic compounds having a hydrolyzable functional group, or an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal 'carbon bond
  • the term “fixing device” refers to a structure (support) that covers a thin film having a network structure containing a functional substance. Unless otherwise specified, when the term ⁇ fixed ridge element '' is used alone, it means a structure that is not coated and is covered with a thin film having a network structure containing a functional substance. Described as “coated immobilized element”.
  • the present invention can be used for screening of drug candidates, clinical examination, or detection of changes in environmental factors, and can also be used as a bioreactor for functional substances, which is simple and inexpensive to manufacture.
  • a variety of physiologically active substances can be used, and a highly functional functional substance-fixing element is provided.
  • FIG. 1 is an electron micrograph showing the structure of the porous immobilization element of the present invention.
  • the space shown in the photograph shows a porous structure with voids of several meters permeable to the solvent.
  • FIG. 2 is an enlarged view further showing an extremely large number of depressions (nm pores) having a diameter of several nm on the surface of the porous structure.
  • FIG. 3 is an enlarged view showing a network structure of a thin film formed on a porous immobilization element of the present invention, in which a surface of a depression (nm pore) of the porous immobilization element is This shows a state in which a thin film having a thickness of several nm is covered.
  • the upper right enlarged portion A shows a state in which the thin film captures and fixes a functional substance in a network structure having voids of several nm.
  • FIG. 4 is a diagram illustrating a sol-gel reaction at the time of forming a thin film of the present invention based on a polymerization reaction of alkoxysilane.
  • FIG. 5 shows that a functional substance is fixed to a network structure of a thin film in the course of polymerization of a monomer generated by hydrolysis of an alkoxysilane in a sol-gel reaction at the time of forming a thin film of the present invention. It is a figure showing a situation.
  • FIG. 6 is a graph showing the activity of immobilized trypsin in Example 2.
  • FIG. 7 is a graph showing the amount of metabolite produced by the action of P450 in Example 4.
  • FIG. 8 is a conceptual diagram showing the relationship between pH conditions and the network structure of a gel.
  • the element for fixing a functional substance used in the present invention is not particularly limited as long as it can be covered with a thin film having a network structure containing the functional substance.
  • the shape can be selected without particular limitation according to the purpose of use.
  • standard or atypical particles such as tablet-like particles or bead-like particles having a size according to the purpose of use, a specified area on a flat or porous substrate, or a cylindrical shape formed on a substrate.
  • An inner wall surface provided with a flat or porous portion of a concave portion such as the above can be used as a fixing device for coating the thin film.
  • it can be used in a small space created using microfabrication technology.
  • the material of the fixing device is not particularly limited as long as it can form a thin film having the network structure on the surface.
  • the immobilizing element is a regular or irregular particle, silicon, silica, quartz, glass, porous glass, carbon, activated carbon, alumina, titer, tantalum oxychloride, germanium, silicon nitride, zeolite, And an organic polymer compound.
  • the fixing element is a specified region of the substrate or an inner wall of a concave portion formed in the substrate, it can be used in combination with glass, ceramics, a polymer, or various porous materials.
  • polystyrene examples include polystyrene, poly (tetra) fluoroethylene (PTFE), polyvinylidene difluoride, polycarbonate, polymethyl methacrylate, polyvinyl ethylene, polyethylene imine, polyvinyl phenol, and polyhydroxyethyl methacrylate.
  • HHEMA polydimethylsiloxane
  • polyacrylamide polyimide
  • block copolymers examples of the polymer include polystyrene, poly (tetra) fluoroethylene (PTFE), polyvinylidene difluoride, polycarbonate, polymethyl methacrylate, polyvinyl ethylene, polyethylene imine, polyvinyl phenol, and polyhydroxyethyl methacrylate.
  • HHEMA polydimethylsiloxane
  • the fixing device according to the present invention can be manufactured by the above-mentioned conventional method according to the purpose of use.
  • the porous immobilization element of the present invention has voids through which the solvent easily passes, and fine irregularities that increase the surface area of the particles or walls constituting the voids.
  • a porous structure having several m, for example 0.1-10 m, preferably 0.3-through holes, which penetrate the solvent, and having a diameter of several nm on the surface of the structure.
  • it is a porous fixing element having pores with a diameter of 11 15 Onm, preferably 11 10 nm.
  • the porosity of the porous fixed element is preferably 40 to 95%, and more preferably 50 to 90%, although it depends on the functional substance used and the properties of the thin film to be coated. surface area ⁇ or lg per 50- 1 that by the structure, 000m 2, particularly preferably a force of some in the 100- 800m 2! / ⁇ .
  • the porous fixing element has a porous structure having voids of several zms permeating the solvent as shown in the photograph of FIG. 1, and when further enlarged, as shown in FIG.
  • the surface of the structure has a very large number of depressions (nm pores) several nm in diameter. Therefore, the surface area of the porous immobilization element is extremely large, and the reaction with the functional substance can be performed efficiently by coating the surface with a thin film containing the functional substance.
  • the porous immobilizing element comprises an organometallic compound having a hydrolyzable functional group, and a non-hydrolyzable organic functional group bonded through Z or at least one metal'carbon bond. And a polymer obtained by hydrolyzing and polymerizing an organometallic compound having a functional group of
  • the organometallic compound includes an organometallic compound containing a metal selected from the group consisting of silicon, titanium, zirconium, and aluminum, and an organometallic compound containing silicon is particularly preferable. In the present invention, these can be used alone or in combination.
  • organometallic compound having a hydrolyzable functional group include a metal alkoxide represented by the following general formula (1).
  • An example of an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal carbon bond is represented by the general formula (2)-(4 )). These metal alkoxides can be used alone or in combination.
  • R—R represents a methyl group, an ethyl group, a propyl group, an aryl group,
  • the porous immobilization element of the present invention is preferably a polymer of tetramethoxysilane, a copolymer of tetramethoxysilane and methyltrimethoxysilane, or a polymer of tetraethoxysilane or 3-trimethoxysilylpropyl methacrylate. Preferred to make up.
  • the porous fixing element can be manufactured as follows.
  • organometallic compound having a hydrolyzable functional group, or a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal'carbon bond.
  • organometallic compound For the hydrolysis, acid catalysts such as hydrochloric acid, sulfuric acid, tosylic acid, and cation exchange resin, and basic catalysts such as ammonium, triethylamine, sodium hydroxide, sodium carbonate, sodium hydrogen carbonate, and anion exchange resin.
  • Polymerization is carried out in water; alcohols such as methanol, ethanol, propanol and butanol; organic solvents such as acetonitrile, tetrahydrofuran and 1,4-dioxane; or a mixed solvent thereof.
  • the reaction temperature is 0 to 120 ° C, preferably 0 to 80 ° C, and the reaction time is 1 minute to 200 hours, preferably 10 minutes to 24 hours.
  • a solvent that causes phase separation in the course of gelation is mixed with a part of the hydrolysis solution.
  • Any solvent that causes phase separation can be used without any particular limitation. Examples thereof include toluene, chloroform, and a polyethylene glycol solution.
  • the mixture is polymerized by thermal polymerization or photopolymerization.
  • a radical generator for example, Irgacure 1800 (Nippon Ciba Geigy Co., Ltd.) is coexisted.
  • the obtained reaction product is washed with an organic solvent such as water or methanol, and dried to obtain a porous fixed device.
  • an organic solvent such as water or methanol
  • the solvent is vaporized to obtain a dried gel porous fixing element.
  • the drying is preferably carried out at 30 to 80 ° C. for several hours to several tens of hours, and thereafter, it is preferably heated to about 200 to 800 ° C. to remove coexisting organic substances.
  • the porous immobilization element of the present invention can be used by covering the entirety or part of a cavity or a column tube, or forming an array of microchips, and coating a functional substance. That is, the organic metal compound having a hydrolyzable functional group or the like is polymerized under appropriate conditions in the inside of the capillaries and the like, and has a porous structure having through holes of several meters that allow the solvent to pass through. In addition, a porous fixed element having pores with a diameter of several nm is formed on the surface of the structure, and then, the functional element is coated on the fixed element. Thus, biochemical or chemical reaction based on the functional substance can be performed, and the product can be easily separated, and the subsequent analysis or recovery process can be continuously performed.
  • the capillaries are preferably 1/200 / ⁇ ⁇ , particularly 50-100 m, and the length is preferably 1 cm-10 m, particularly 10 cm-lm. If the length force is less than 1 cm, sufficient separation is not performed, and if it exceeds 10 m, it takes a long time for separation, which is not preferable.
  • the column tube may be made of glass, stainless steel, plastic, or fluorine resin (for example, Teflon (registered trademark)) without any particular limitation.
  • the inner wall surface of the concave portion such as a cylindrical shape formed on the substrate, which is provided with a flat or porous portion, that is, the inner wall of the assemble plate can be used as a fixing element for the thin film.
  • the assay plate contains 6, 12, 24, 48, 96, 386, or 1536 pills formed on one plate, and the inner wall of these pills is used as an immobilization element. Can be. If necessary, the above-mentioned organometallic compound having a hydrolyzable functional group is polymerized under appropriate conditions on these inner wall surfaces, or separately prepared. The particles of the formed porous fixing element can be fixed and used as the porous fixing element.
  • the term “functional substance” refers to a substance that causes or catalyzes a chemical, biochemical, or biological reaction, and includes not only physiologically active substances such as enzymes, hormones, and antibodies, but also , Containing a wide range of active substances. As long as it can be used by being fixed to the thin film having a network structure of the present invention, it can be used as the functional substance without any particular limitation.
  • Such functional substances include metabolic enzymes such as P450 and dalcuronyltransferase; proteins such as protein hydrolases such as trypsin and pepsin; nucleic acids, fats, sugars, physiologically active properties such as drugs, and metal catalysts. Synthetic functional materials, such as, fullerene, carbon nanotubes, polymorphic taxanes, catenane, and other specific shaped compounds. Examples of the drug include aspirin, morphine, tetrodotoxin and the like.
  • various metabolic enzymes which are particularly unstable and easily deactivated, can be used by immobilizing them on a thin film in a form included in a micronome.
  • a sol solution of an organometallic compound containing a functional substance is prepared. Hydrolyzing an organometallic compound having a hydrolyzable functional group, or an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal 'carbon bond Decompose.
  • acid catalysts such as hydrochloric acid, sulfuric acid, tosylic acid, and cation exchange resin
  • basic catalysts such as ammonium, triethylamine, sodium hydroxide, sodium carbonate, sodium hydrogen carbonate, and anion exchange resin.
  • Water; alcohols such as methanol, ethanol, propanol and butanol; organic solvents such as acetonitrile, tetrahydrofuran and 1,4-dioxane; or a mixed solvent thereof.
  • the molar ratio between the organometallic compound and the solvent varies depending on the organometallic compound used, the solvent, and the like, but is preferably 3: 1 to 1:10, particularly preferably 1: 1 to 1: 4.
  • the reaction temperature is 0 to 120 ° C, preferably 0 to 80 ° C, and the reaction time is 1 minute to 200 hours, preferably 10 minutes to 24 hours.
  • the hydrolysis solution is mixed with a solution containing a functional substance.
  • the mixture It is called a sol solution.
  • the functional substance is a biological substance such as an enzyme, it is preferably dissolved in a buffer solution.
  • the gel has a chain structure with large voids when the pH is on the acidic side, and has a network with many branches when the pH is on the basic side.
  • the porous immobilization element is immersed in the sol solution, the excess of the porous immobilization element force is also removed, and the porous immobilization element is removed by drying.
  • a thin film containing a functional substance can be applied on the surface of the quality fixing device. The higher the drying temperature, the faster the drying proceeds.
  • the functional substance is a physiologically active substance, it is 0 to 30 ° C, preferably 0 to 20 ° C to prevent denaturation or decrease in activity. ° C, more preferably 0 ° C-10 ° C.
  • porous fixed element coated with a thin film having a network structure containing a functional substance can be taken out of the assay plate and reused for each measurement. Measurement and regeneration can be repeated.
  • the sol-gel reaction at the time of forming the thin film will be described based on a polymerization reaction of alkoxysilane.
  • a desired gel is obtained by hydrolyzing a predetermined alkoxysilane and polycondensing a produced monomer.
  • the functional substance is fixed to the thin-film network structure in the process in which the monomer is polymerized to form a network structure.
  • the surface of the depression (nm pore) of the porous immobilization element is covered with a thin film of 110, 10 nm and a thickness of OOOnm.
  • the thin film captures and fixes the functional substance in a network structure having voids of 0.1 to 50 nm.
  • the microsomes used in the present invention can purify the power of rat liver and the like by a conventional method.
  • a micronome in which P450 and DARC-transferase are introduced is commercially available (Daiichi Pure Chemicals).
  • a porous fixing element coated with a thin film of a functional substance is put in or fixed in a well of an atsie plate, and a biochemical or chemical reaction is performed by the functional substance.
  • a functional substance can be coated with a thin film using the inner wall of the well as a fixing element.
  • the assay plate a plate having 6, 12, 24, 48, 96, 386, or 1536 beads on a single plate is commercially available. Is changed appropriately to make the size suitable for these wells. After performing a predetermined reaction, the activity can be measured using a plate reader or the like.
  • a fused silica cavity with a 5 cm long porous immobilization element coated with a thin film containing pepsin (Wako Pure Chemicals) (75 ⁇ m id, lm length, Polymicro Technologies INC.).
  • the pepsin-fixed column used in this example was manufactured by the following procedure. To 750 ⁇ l of 3-trimethoxysilylpropyl methacrylate (MTMSP) (Tokyo Kasei), 225 ⁇ l of water and 22.5 ⁇ l of 1M HC1 were added, and the mixture was stirred at room temperature for 30 minutes. After adding 170 ⁇ l of toluene to 30 ⁇ l of the solution and stirring again for 30 minutes, 8.9 mg of Irgacure 18OO (Irgacurel 800 (Nippon Chino, Geigy One)) was added, and the mixture was further stirred for 2.5 hours or more.
  • MTMSP 3-trimethoxysilylpropyl methacrylate
  • Irgacure 18OO Irgacurel 800 (Nippon Chino, Geigy One)
  • a fixed polymer element was prepared in a capillary by a photopolymerization reaction.
  • a RPR-100 photochemical reactor Ultraviolet Company, Branford, CT, U, A. After removing the unreacted solution with methanol, the mixture was allowed to stand in an oven at 110 ° C. and dried.
  • Tetramethoxysilane (TMOS) (Tokyo Kasei Co., Ltd.) was added with 169 ⁇ l of water and 11 ⁇ l of 0.01% HC1 to 761 ⁇ l, and the mixture was stirred at room temperature for 20 minutes. After mixing 150 ⁇ l of 150 mM phosphate buffer (pH 5.5) 601 containing 25% (w / v) pepsin in 20 ⁇ l of the solution, the sol solution was immersed so that only the immobilizing element was immersed. It was introduced into the capillary with a syringe. After leaving at 4 ° C for 5 minutes, the mixed solution was expelled from the capillary force and allowed to stand at 4 ° C for 2 days or more to prepare a thin film containing pepsin on the immobilized element.
  • TMOS Tetramethoxysilane
  • the electrophoresis apparatus 3 D CE system manufactured by Agilent Technologies, the mass spectrometer using MSD mass spectrometer.
  • a 500 mM formic acid solution (Wako Pure Chemical Industries) was used as the electrophoresis solution.
  • a 15 kV potential difference was applied to both ends of the capillary at the time of analysis, and the liquid was sent at a pressure of 50 mbar from one end of the porous fixed element. went.
  • the sample contains insulin chains (
  • the injected sample was digested by a porous immobilizing element coated with a thin film containing pepsin, and the generated peptide fragments were separated by electrophoresis and directly introduced into a mass spectrometer for detection.
  • the detected peptide fragment had undergone an enzyme-specific cleavage that would occur when the sample was digested with pepsin.
  • the protein of the sample was identified by using Protein Prospector 4.0.5 (the University of California, San Francisco, http://prospector.ucsf.edu) which is a protein identification software using the generated peptide fragment.
  • the activity of pepsin was maintained even when the detection step was performed 30 times in succession and analyzed.
  • the trypsin thin-film fixed device used in this example was manufactured by the following procedure. 2.5 ml of polyethylene glycol dissolved in 1 ml of tetramethoxysilane (TMOS) (Tokyo Kasei) was added with 2.5 ml of 0.01M acetic acid and stirred at 0 ° C for 45 minutes. The solution was left standing at 40 ° C for 1 ⁇ to carry out the polymerization reaction, washed with water, molded into the desired shape, and treated with 0.01M ammonia water at 120 ° C for 3 hours Thereafter, it was washed again with water and dried at 40 ° C. for 3 days. The polymer was heated at 600 ° C. for 2.5 hours to produce a porous fixed device.
  • TMOS tetramethoxysilane
  • TMOS tetramethoxysilane
  • HC1 tetramethoxysilane
  • 5 OmM Tris-HCl buffer (pH 7.0) 1201 containing 5% (w / v) trypsin in 120 ⁇ l was mixed with 5 OmM Tris-HCl buffer (pH 7.0) 1201 containing 5% (w / v) trypsin in 120 ⁇ l, followed by mixing the sol solution with the porous immobilization element for 5 minutes.
  • the porous immobilized device was immersed, taken out, and allowed to stand at 4 ° C. for 2-3 days to form a trypsin-containing thin film on the surface of the porous immobilized device.
  • a fixing device was manufactured in the same procedure as in Example 2. Next, 171 ⁇ l of water and 11 ⁇ l of 0.01% of HC1 were added to 761 ⁇ l of tetramethoxysilane (TMOS) (Tokyo Danisei), and the mixture was stirred at room temperature for 20 minutes. A microsomal (Daiichi Pure Chemicals) solution containing ⁇ 450 in 20 ⁇ l of the solution (protein concentration: 2.75 mgZml) 100 1 was added and stirred, and the porous immobilizing device was immersed in the mixed solution. After drying for 2 days or more, a P450-containing thin film was formed on the surface of the porous fixed device.
  • the porous immobilization element has a through hole of 0.3 to 6 ⁇ m through which a solvent can pass, and further has a pore size of 110 nm to increase the surface area. It was expected to increase.
  • the coating of the micronome involves the hydrolysis and polymerization of the alkoxysilane, the microsomes are included in the cross-linked structure under mild conditions, and the method is adapted to a high-throughput screening system using a means for immobilization.
  • a 96-well microplate was used, and a porous immobilization element was manufactured so as to have a size that would fit in a well.
  • a porous fixing element coated with a thin film containing P450 and a fluorescent substrate ethoxyresorufin solution were placed in a well of a 96-well microplate and reacted at 37 ° C. The reaction occurs as shown in the following chemical formula (5).
  • P450 metabolic activity remove the porous immobilization element, the generation amount of Rezorufuin raw form by using the plate reader was determined by fluorescence measurement (Ex.550nm, Em.590 nm) 0 After the measurement By washing and drying the porous immobilizing element with a 20 mM phosphate buffer (pH 7.4), measurement could be repeated four times for four days.
  • P450 was easily inactivated and could not be used in a fixed manner, and P450 power S had to be separated from P450 in order to prevent the measurement of S metabolic activity.
  • P450 can be used repeatedly, and it is necessary to separate metabolites to be measured from P450. Disappeared, and analysis became possible with a small amount of sample and reagent. That is, according to the present invention, analysis using P450 can be performed economically and in a short time.
  • Example 4 Example in which a thin film containing microsomes containing P450 is formed directly on the bottom of a well of a 96-well microplate and oxidized.
  • TMOS tetramethoxysilane
  • FIG. 7 is a graph showing the relationship between the elapsed time and the amount of resolufin generated. Also in the case of the P450 fixed device manufactured by this method, measurement was possible repeatedly 13 times for 6 days.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

[PROBLEMS] To provide a functional substance immobilization element which can be used in drug candidate compound screening and clinical test or detection of environmental factor variation and can be used as a functional substance bioreactor and which can be easily produced and are available at low price, excelling in the variety of applicable physiologically active substance and the functional capability. [MEANS FOR SOLVING PROBLEMS] An immobilization element coated with a thin film wherein a functional substance is incorporated in a network structure of nanometer order; a porous immobilization element having pores of nanometer order; and a process for forming the thin film on the immobilization element.

Description

明 細 書  Specification

機能性物質含有薄膜で被覆された固定化素子、及びその製造法 技術分野  Immobilized element covered with a functional substance-containing thin film and method for producing the same

[0001] 本発明は、機能性物質含有薄膜で被覆された固定ィ匕素子、及びその製造方法に 関する。詳細に述べると、本発明は、ナノメートル単位の網状構造内に機能性物質を 包含した薄膜に被覆された固定ィ匕素子、ナノメートル単位の細孔を有する多孔質固 定化素子、及び該薄膜を固定ィ匕素子上に形成する方法に関するものである。  The present invention relates to a fixing device covered with a functional substance-containing thin film and a method for producing the same. More specifically, the present invention relates to an immobilization device coated with a thin film containing a functional substance in a network structure in nanometer units, a porous immobilization device having pores in nanometer units, and The present invention relates to a method for forming a thin film on a fixed element.

背景技術  Background art

[0002] 従来から、酵素、抗体、又は生理活性物質などの機能性物質を利用して、医薬候 補ィ匕合物のスクリーニング、診断用データを得るための臨床検査、及び環境因子変 動の検出などが行われ、またこれら機能性物質をバイオリアクターとして用い、有用 化合物が製造されている。  [0002] Conventionally, screening of drug candidate conjugates, clinical tests for obtaining diagnostic data, and changes in environmental factors using functional substances such as enzymes, antibodies, or physiologically active substances have been performed. Detection and the like are performed, and useful compounds are produced using these functional substances as bioreactors.

これらの機能性物質は、効率的、かつ経済的に繰り返し使用するため、又は反応 効率及び検出感度 ·効率を向上させるため、様々な担体に固定して利用されてきた。 例えば、機能性物質として幅広く利用されているタンパク質の固定ィ匕法を挙げると、 不溶性の担体にタンパク質を結合させる担体結合法、酵素を 2個以上の官能基を有 する試薬と反応させる架橋法、ゲルの微細な格子の中に包み込むか、半透膜性のポ リマーの皮膜により被覆する包括法などがある。  These functional substances have been used by immobilizing them on various carriers for efficient and economical repeated use or for improving the reaction efficiency and the detection sensitivity and efficiency. For example, a protein immobilization method widely used as a functional substance includes a carrier binding method in which a protein is bound to an insoluble carrier, and a crosslinking method in which an enzyme is reacted with a reagent having two or more functional groups. Inclusion methods include wrapping in a fine gel lattice or covering with a semipermeable polymer film.

[0003] 該担体結合法には、 Glassmeyer, C. K.らのアミノエチルセルロースを担体として、グ ルタルアルデヒドを用いてトリプシンを固定ィ匕する方法があり(非特許文献 1)、例えば 、生理活性物質を担体上に固定した固定ィ匕酵素製剤 (特許文献 1)や不溶性マトリツ タス上に固定化されたリパーゼ複合体 (特許文献 2)などが開発されている。該担体 結合法は、共有結合による固定ィ匕法なので、酵素が簡単に脱離することは無いが、 反応操作が複雑で、比較的激し 、処理をするため生物活性作用物質であるタンパク 質の高次構造の変化、活性の低下などが起こりやすいという欠点がある。  [0003] As the carrier binding method, there is a method of immobilizing trypsin using glutaraldehyde using aminoethylcellulose such as Glassmeyer and CK (Non-Patent Document 1). An immobilized enzyme preparation immobilized thereon (Patent Document 1) and a lipase complex immobilized on insoluble matrix (Patent Document 2) have been developed. Since the carrier binding method is an immobilization method using a covalent bond, the enzyme is not easily desorbed, but the reaction operation is complicated, relatively intense, and a protein that is a biologically active substance because of the treatment. However, there is a disadvantage that changes in the higher-order structure and a decrease in activity are likely to occur.

該架橋法には、 Quiocho, F.A.らのダルタルアルデヒドを用いて酵素間にシッフ塩基 を形成させて架橋し、カルボキシぺプチダーゼ Aを固定ィ匕する方法があり(非特許文 献 2)、例えば、カルボン酸エステル結合を有するカップリング剤を無機担体に結合さ せることにより製造した固定化リパーゼ (特許文献 3)、及び生物活性作用物質を有 機膜上に固定した基板カゝらなる生体分子スクリーニング用デバイス (特許文献 4)など が開発されている。しかし、該架橋法も担体結合法と比較すると簡便ではあるものの 、生物活性物質を共有結合を介して行うため、活性の低下が起こりやすいという欠点 がある。 As the cross-linking method, there is a method in which a Schiff base is formed between enzymes by using dartartaldehyde of Quiocho, FA and the like to cross-link and immobilize carboxypeptidase A (Non-patent document). (2) For example, immobilized lipase produced by binding a coupling agent having a carboxylic acid ester bond to an inorganic carrier (Patent Document 3), and a substrate substrate having a bioactive agent immobilized on an organic film A flat biomolecule screening device (Patent Document 4) and the like have been developed. However, although the cross-linking method is simpler than the carrier-binding method, it has a drawback that the activity tends to decrease because the bioactive substance is carried out through a covalent bond.

[0004] さらに、該包括法には、 Bernfeld, P.らの、目的の酵素液に、アクリルアミドモノマー、 架橋剤、重合促進剤、重合開始剤などを加えて重合させ、トリプシン、アミラーゼなど をゲル内に取り込む方法がある(非特許文献 3)。この方法は、担体結合法や架橋法 と異なり、生理活性物質と担体とをィ匕学結合させる必要はないので、活性低下が起こ り難いという利点がある力 一方、個々の生理活性物質が担体と結合反応していない ので強度が低くなりやす!/、と 、う欠点があった。  [0004] Furthermore, in the entrapment method, Bernfeld, P. et al. Add an acrylamide monomer, a cross-linking agent, a polymerization accelerator, a polymerization initiator, and the like to an enzyme solution of interest, and polymerize the solution. There is a method of capturing the information in the inside (Non-Patent Document 3). Unlike the carrier binding method and the cross-linking method, this method does not require the biologically active substance to be bonded to the carrier, and thus has the advantage that the activity does not easily decrease. Since there is no binding reaction, the strength tends to be low! /

また、 Ellerbyらにより開発された、アルコキシシランを用いたゾルーゲル法により、緩 衝液に溶解したタンパク質をシリカマトリックス内に包含する方法がある(非特許文献 4)。この方法により高次構造と生理活性を保持したまま、生理活性物質を固定してバ ィォリアクターとして応用することができる力 ゾルーゲルイ匕反応後、各種用途に応じ てゲルの乾燥、粉砕などの処理を行うと、固定ィ匕タンパク質などの活性が低下し、ま た、処理プロセスが煩雑であると!/、つた欠点があった。  In addition, there is a method developed by Ellerby et al. In which a protein dissolved in a buffer solution is included in a silica matrix by a sol-gel method using alkoxysilane (Non-Patent Document 4). By this method, a bioactive substance can be fixed and applied as a bioreactor while retaining the higher-order structure and biological activity. After the sol-gel reaction, the gel is dried and crushed according to various uses. When the activity of immobilized protein and the like was reduced, and the treatment process was complicated! /

[0005] これらの固定化法は、これまで記載したように生理活性物質が固定化に適した官能 基を有することが必要なため限られたものしか固定できない、固定化操作に多くの反 応、精製操作が必要なため、煩雑でコストが高い、又は安定した生理活性物質しか 固定できな ヽなどの欠点があった。  [0005] In these immobilization methods, as described above, since a physiologically active substance needs to have a functional group suitable for immobilization, only a limited number can be immobilized. However, since a purification operation is required, there are drawbacks such as that the method is complicated and expensive, or that only a stable physiologically active substance can be immobilized.

[0006] このような状況にあって、近年、技術の進歩に伴い、医薬候捕ィ匕合物のスクリー二 ング、臨床検査、環境因子変動の検出、及び機能性物質のバイオリアクターとして機 能性物質が盛んに利用されるようになっている。また、コンビナトリアルケミストリーな どの進歩に伴い、伝統的な手法によって調製される化合物、及び天然の産物の抽出 物などと比べ、医薬候補となり得る化合物の数は著しく増加しており、有用な医薬と なる化合物を発見するためにより高効率のスクリーニングが必要となっている。 これらの要望に応えるため、製造が簡単で値段が安ぐ利用できる生理活性物質が 多様で、かつ高機能の機能性物質固定ィ匕素子が必要とされて 、る。 [0006] In such a situation, in recent years, with the advancement of technology, it has functioned as a screening, clinical examination, detection of fluctuations in environmental factors, and a bioreactor for functional substances, with the use of a pharmaceutical compound. Sexual substances are being actively used. In addition, along with advances in combinatorial chemistry and the like, the number of compounds that can be drug candidates has increased significantly compared to compounds prepared by traditional methods and extracts of natural products, making them useful drugs. More efficient screening is needed to find compounds. In order to meet these demands, there is a need for a functional substance-fixing element having a variety of bioactive substances which are easy to manufacture and inexpensive and can be used, and which have high functions.

[0007] 特許文献 1:特開平 2000-83663号公報 Patent Document 1: Japanese Patent Application Laid-Open No. 2000-83663

特許文献 2:特表 2002-539782号公報  Patent Document 2: Japanese Patent Publication No. 2002-539782

特許文献 3 :特開平 9-313179号公報  Patent document 3: JP-A-9-313179

特許文献 4:特表 2002-520621号公報  Patent Document 4: Japanese Patent Publication No. 2002-520621

非特許文献 l : Glassmeyer, C. K.et. al, Biochemistry, 1971, 10, 786.  Non-Patent Document l: Glassmeyer, C.K.et.al, Biochemistry, 1971, 10, 786.

非特許文献 2 : Quiocho, F.A. et. al, Proc. Nat. Acad. Sci. 1964, 52, 833 非特許文献 3 : Bernfeld, P.et. al, Science, 142, 678, 1963  Non-Patent Document 2: Quiocho, F.A. et.al, Proc.Nat.Acad.Sci. 1964, 52, 833 Non-Patent Document 3: Bernfeld, P. et.al, Science, 142, 678, 1963

非特許文献 4 : Ellerby et.al, Science, 1992, 255, 1113-1115  Non-patent document 4: Ellerby et.al, Science, 1992, 255, 1113-1115

発明の開示  Disclosure of the invention

発明が解決しょうとする課題  Problems to be solved by the invention

[0008] 本発明は、医薬候補ィ匕合物のスクリーニング、臨床検査、又は環境因子変動の検 出に利用でき、さらに機能性物質のバイオリアクターとして利用ができ、製造が簡単 で値段が安ぐ利用できる生理活性物質が多様で、かつ高機能の機能性物質固定 化素子を提供することを目的とする。 [0008] The present invention can be used for screening drug candidates, for clinical tests, or for detecting changes in environmental factors, and can also be used as a bioreactor for functional substances, and is simple and inexpensive to manufacture. It is an object of the present invention to provide a functional substance-immobilizing element having a wide variety of usable physiologically active substances and a high functionality.

課題を解決するための手段  Means for solving the problem

[0009] 前記目的を達成するため研究を行った結果、本発明者らは、加水分解性の官能基 を有する有機金属化合物と機能活性物質とを含むゾル反応溶液を、固定化素子上 でゲルイ匕することにより、固定化素子上に、生理活性物質を保持した数ナノメートル( 以下、 nmと略す。)の空隙を有する網状構造を持つ薄膜を形成できるという知見を 得た。 [0009] As a result of conducting research to achieve the above object, the present inventors have found that a sol reaction solution containing an organometallic compound having a hydrolyzable functional group and a functional active substance is gelled on an immobilized element. It was found that by shading, a thin film having a network structure having voids of several nanometers (hereinafter abbreviated as nm) holding a physiologically active substance could be formed on the immobilized element.

さらに、不安定で細胞外では容易に活性を失う代謝酵素などの生理活性物質をミ クロノームに包含させ、該ミクロノームと加水分解性の官能基を有する有機金属化合 物とを含むゾル反応溶液を、固定ィ匕素子上でゲルィ匕することにより、固定化素子上 に、安定的な形態で生理活性物質を含有したミクロソームを保持した数 nmの空隙を 有する網状構造を持つ薄膜を形成できると!ヽぅ知見を得た。  Furthermore, a physiologically active substance such as a metabolic enzyme which is unstable and easily loses its activity outside the cell is included in the micronome, and a sol reaction solution containing the micronome and an organometallic compound having a hydrolyzable functional group is prepared. By gelling on the immobilization device, it is possible to form a thin film having a network structure with several nm voids holding microsomes containing a physiologically active substance in a stable form on the immobilization device! ヽぅ Obtained knowledge.

[0010] さらに、本発明者らは、加水分解性の官能基を有する有機金属化合物を特定の条 件下で処理することにより、溶媒を透過する数 W mの貫通孔を有する多孔質構造を 有し、かつ該構造表面に直径数 nmの細孔を有する多孔質固定ィ匕素子を製造できる という知見を得た。本発明は、これらの知見に基づき完成されたものである。 [0010] Further, the present inventors have proposed an organometallic compound having a hydrolyzable functional group under a specific condition. By treating under the above conditions, it is possible to produce a porous fixed element having a porous structure having a through hole of several Wm that is permeable to a solvent, and having pores of several nm in diameter on the surface of the structure. Obtained knowledge. The present invention has been completed based on these findings.

したがって、本発明は、機能性物質を包含した網目状構造の薄膜で被覆された固 定化素子、特に多孔質固定化素子を提供する。  Therefore, the present invention provides an immobilized element, particularly a porous immobilized element, which is covered with a thin film having a network structure containing a functional substance.

[0011] また、本発明は、該固定化素子が、溶媒を透過する 0. 1— 10. O /z mの貫通孔を 有する多孔質構造を有し、かつ該構造表面に直径 1一 lOOnmの細孔を有する多孔 質固定ィ匕素子であることを特徴とする、機能性物質を包含した網目状構造の薄膜で 被覆された固定ィ匕素子を提供する。 [0011] Further, according to the present invention, the immobilization element has a porous structure having a through-hole of 0.1-10 O / zm, which is permeable to a solvent, and has a diameter of 11-100 nm on the surface of the structure. Disclosed is a fixing device which is a porous fixing device having pores and is coated with a thin film having a network structure containing a functional substance.

また、本発明は、該機能性物質が、タンパク質、核酸、脂質、糖、薬物等の生理活 性物質、金属触媒、特異的な形状の化合物からなる群から選ばれる少なくとも 1種で あることを特徴とする、前記被覆された固定化素子を提供する。  Further, the present invention provides that the functional substance is at least one selected from the group consisting of a physiologically active substance such as a protein, a nucleic acid, a lipid, a sugar, a drug, a metal catalyst, and a compound having a specific shape. A coated immobilized element is provided.

[0012] また、本発明は、機能性物質を含むミクロソームを包含した網目状構造の薄膜で被 覆された固定化素子、特に多孔質固定化素子を提供する。 [0012] The present invention also provides an immobilization element, particularly a porous immobilization element, which is covered with a network-like thin film containing microsomes containing a functional substance.

また、本発明は、該固定化素子が、溶媒を透過する数/ z mの貫通孔を有する多孔 質構造を有し、かつ該構造表面に直径数 nmの細孔を有する、多孔質固定化素子で あることを特徴とする、機能性物質を含むミクロソームを包含した網目状構造の薄膜 で被覆された固定化素子を提供する。  Further, the present invention provides a porous immobilization element, wherein the immobilization element has a porous structure having several / zm through-holes permeable to a solvent and has pores having a diameter of several nm on the surface of the structure. The present invention provides an immobilization element covered with a network-like thin film containing microsomes containing a functional substance.

[0013] また、本発明は、該機能性物質が、 P450、又はダルク口-ルトランスフェラーゼなど の代謝酵素である、機能性物質を含むミクロソームを包含した網目状構造の薄膜で 被覆された固定ィ匕素子を提供する。 [0013] Further, the present invention provides an immobilization device, wherein the functional substance is coated with a thin film having a network structure including microsomes containing the functional substance, which is a metabolic enzyme such as P450 or Darc-transferase. A dani element is provided.

また、本発明は、機能性物質を包含した網目状構造の薄膜、又が機能性物質を含 むミクロソームを包含した網目状構造の薄膜で被覆された多孔質固定ィ匕素子が内部 に形成されて ヽるカラム、又はマイクロチップを提供する。  In addition, the present invention provides a thin film having a network structure containing a functional substance, or a porous immobilization element covered with a thin film having a network structure containing microsomes containing a functional substance. Provide a column or microchip.

[0014] また、本発明は、固定化素子上に機能性物質を含む網目状構造の薄膜を被覆す る方法であって: Further, the present invention is a method for coating a thin film having a network structure containing a functional substance on an immobilization element, comprising:

加水分解性の官能基を有する有機金属化合物、又は少なくとも 1個の金属'炭素 結合を介して結合した非加水分解性の有機官能基と加水分解性の官能基とを含む 有機金属化合物を加水分解すること;該加水分解溶液と、機能性物質を含有する溶 液とを混合してゾル溶液を得ること;及び該ゾル溶液に、固定化素子を浸漬し、乾燥 させることにより、該固定ィ匕素子の表面上に薄膜を形成することを含む、前記薄膜の 被覆方法を提供する。 Organometallic compound having a hydrolyzable functional group, or contains a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal 'carbon bond Hydrolyzing an organometallic compound; mixing the hydrolysis solution with a solution containing a functional substance to obtain a sol solution; and immersing the immobilizing element in the sol solution and drying. Accordingly, the present invention provides a method for coating the thin film, comprising forming a thin film on the surface of the fixing device.

また、本発明は、溶媒を透過する 0. 1— 10. O /z mの貫通孔を有する多孔質構造 を有し、かつ該構造表面に直径 1一 lOOnmの細孔を有する多孔質固定ィ匕素子を提 供する。  In addition, the present invention provides a porous immobilization film having a porous structure having a through hole of 0.1-10 O / zm that is permeable to a solvent, and having pores having a diameter of 11 lOO nm on the surface of the structure. Provide device.

[0015] また、本発明は、前記多孔質固定化素子の製造方法であって:  [0015] Further, the present invention is a method for producing the porous immobilized element, comprising:

加水分解性の官能基を有する有機金属化合物、又は少なくとも 1個の金属'炭素 結合を介して結合した非加水分解性の有機官能基と加水分解性の官能基とを含む 有機金属化合物を加水分解すること;該加水分解溶液にゲル化の過程で相分離を 引き起こす溶媒を混合すること;及び該混合液を熱重合、又は光重合により重合させ ることを含む、前記製造方法を提供する。  Hydrolyzes organometallic compounds having a hydrolyzable functional group, or an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal 'carbon bond Providing a solvent that causes phase separation in the course of gelation with the hydrolysis solution; and polymerizing the mixture by thermal polymerization or photopolymerization.

本明細書で用いる用語「固定ィ匕素子」とは、機能性物質を含む網目状構造の薄膜 を被覆する構造体 (支持体)を意味する。特に断らない限り、該用語「固定ィ匕素子」を 単独で用いる場合、被覆されて ヽな ヽ構造体を意味し、機能性物質を含む網目状構 造の薄膜で被覆されて 、る場合、「被覆された固定化素子」と記載する。  As used herein, the term “fixing device” refers to a structure (support) that covers a thin film having a network structure containing a functional substance. Unless otherwise specified, when the term `` fixed ridge element '' is used alone, it means a structure that is not coated and is covered with a thin film having a network structure containing a functional substance. Described as “coated immobilized element”.

発明の効果  The invention's effect

[0016] 本発明により、医薬候補ィ匕合物のスクリーニング、臨床検査、又は環境因子変動の 検出に利用でき、さらに機能性物質のバイオリアクターとして利用ができ、製造が簡 単で値段が安ぐ利用できる生理活性物質が多様で、かつ高機能の機能性物質固 定ィ匕素子が提供される。  [0016] According to the present invention, it can be used for screening of drug candidates, clinical examination, or detection of changes in environmental factors, and can also be used as a bioreactor for functional substances, which is simple and inexpensive to manufacture. A variety of physiologically active substances can be used, and a highly functional functional substance-fixing element is provided.

図面の簡単な説明  Brief Description of Drawings

[0017] [図 1]図 1は、本発明の多孔質固定化素子の構造を示す電子顕微鏡写真である。該 写真に示されている空間は、溶媒を透過する数 mの空隙を有する多孔性構造を示 す。  FIG. 1 is an electron micrograph showing the structure of the porous immobilization element of the present invention. The space shown in the photograph shows a porous structure with voids of several meters permeable to the solvent.

[図 2]図 2はさらに、前記多孔性構造の表面にある極めて多くの直径数 nmの窪み (n m細孔)を示す拡大図である。 [図 3]図 3は、本発明の多孔質固定ィ匕素子上に形成された薄膜の網状構造を示す拡 大図であり、多孔質固定化素子の窪み (nm細孔)の表面を、厚さ数 nmの薄膜が覆 つている状態を示す。右上拡大部分 Aは、該薄膜がその数 nmの空隙を有する網状 構造の中に機能性物質を捉えて固定して ヽる状態を示す。 FIG. 2 is an enlarged view further showing an extremely large number of depressions (nm pores) having a diameter of several nm on the surface of the porous structure. FIG. 3 is an enlarged view showing a network structure of a thin film formed on a porous immobilization element of the present invention, in which a surface of a depression (nm pore) of the porous immobilization element is This shows a state in which a thin film having a thickness of several nm is covered. The upper right enlarged portion A shows a state in which the thin film captures and fixes a functional substance in a network structure having voids of several nm.

[図 4]図 4は、本発明の薄膜作成時のゾルーゲル反応をアルコキシシランの重合反応 に基づき説明した図である。  FIG. 4 is a diagram illustrating a sol-gel reaction at the time of forming a thin film of the present invention based on a polymerization reaction of alkoxysilane.

[0018] [図 5]図 5は、本発明の薄膜作成時のゾルーゲル反応において、アルコキシシランの 加水分解により生成したモノマーが、重合する過程で、機能性物質を、薄膜の網状 構造に固定する状況を示す図である。 [FIG. 5] FIG. 5 shows that a functional substance is fixed to a network structure of a thin film in the course of polymerization of a monomer generated by hydrolysis of an alkoxysilane in a sol-gel reaction at the time of forming a thin film of the present invention. It is a figure showing a situation.

[図 6]図 6は、実施例 2における、固定されたトリプシンの活性を示すグラフである。  FIG. 6 is a graph showing the activity of immobilized trypsin in Example 2.

[図 7]図 7は、実施例 4において、 P450の作用による代謝生成物の産生量を示すグ ラフである。  FIG. 7 is a graph showing the amount of metabolite produced by the action of P450 in Example 4.

[図 8]図 8は、 pHの条件とゲルの網状構造との関係を示す概念図である。  FIG. 8 is a conceptual diagram showing the relationship between pH conditions and the network structure of a gel.

発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION

[0019] (固定化素子) [0019] (immobilization element)

本発明で用いる機能性物質の固定ィ匕素子は、機能性物質を包含した網目状構造 の薄膜で被覆できるものであれば、特に限定されない。また、その形状は、使用目的 に合わせ特に制限なく選択することができる。例えば、使用目的に応じた大きさを有 するタブレット状粒子、又はビーズ状粒子などの定型又は非定型粒子、平坦な又は 多孔質部を設けた基板上の規定領域、基板に形成された円筒形などの凹部の、平 坦な又は多孔質部を設けた内壁面などを、該薄膜を被覆する固定ィ匕素子として用い ることができる。また微細加工技術を利用して作製される微小空間内での利用も可能 である。  The element for fixing a functional substance used in the present invention is not particularly limited as long as it can be covered with a thin film having a network structure containing the functional substance. Further, the shape can be selected without particular limitation according to the purpose of use. For example, standard or atypical particles such as tablet-like particles or bead-like particles having a size according to the purpose of use, a specified area on a flat or porous substrate, or a cylindrical shape formed on a substrate. An inner wall surface provided with a flat or porous portion of a concave portion such as the above can be used as a fixing device for coating the thin film. In addition, it can be used in a small space created using microfabrication technology.

また、固定ィ匕素子の材質は、表面に前記網目状構造の薄膜を形成できるものであ れば、特に限定されない。例えば、該固定化素子が定型又は非定型粒子である場合 、シリコン、シリカ、石英、ガラス、多孔質ガラス、炭素、活性炭、アルミナ、チタ-ァ、 酸ィ匕タンタル、ゲルマニウム、窒化シリコン、ゼォライト、及び有機ポリマー化合物など を使用することができる。 [0020] また、固定ィ匕素子が基板の規定領域、又は基板に形成された凹部の内壁である場 合、ガラス、セラミックス、ポリマー、又は各種多孔質材料と組み合わせて用いることが できる。該ポリマーの例を挙げると、ポリスチレン、ポリ(テトラ)フルォロエチレン(PTF E)、ポリビ-リデンジフルオリド、ポリカーボネート、ポリメチルメタタリレート、ポリビ- ルエチレン、ポリエチレンィミン、ポリビニルフエノール、ポリヒドロキシェチルメタクリレ 一 HHEMA)、ポリジメチルシロキサン、ポリアクリルアミド、ポリイミド、及びこれらの ブロックコポリマーがある。本発明の固定ィ匕素子は、その使用目的に応じて、前記材 料力 常法で製造することができる。 Further, the material of the fixing device is not particularly limited as long as it can form a thin film having the network structure on the surface. For example, when the immobilizing element is a regular or irregular particle, silicon, silica, quartz, glass, porous glass, carbon, activated carbon, alumina, titer, tantalum oxychloride, germanium, silicon nitride, zeolite, And an organic polymer compound. When the fixing element is a specified region of the substrate or an inner wall of a concave portion formed in the substrate, it can be used in combination with glass, ceramics, a polymer, or various porous materials. Examples of the polymer include polystyrene, poly (tetra) fluoroethylene (PTFE), polyvinylidene difluoride, polycarbonate, polymethyl methacrylate, polyvinyl ethylene, polyethylene imine, polyvinyl phenol, and polyhydroxyethyl methacrylate. HHEMA), polydimethylsiloxane, polyacrylamide, polyimide, and their block copolymers. The fixing device according to the present invention can be manufactured by the above-mentioned conventional method according to the purpose of use.

本発明の多孔質固定化素子は、溶媒が容易に通過する空隙、及び該空隙を構成 する粒子、又は壁に表面積を広げる微細な凹凸を有することが好ましい。特に好まし いのは、溶媒を透過する数 m、例えば 0. 1— 10 m、好ましくは 0. 3— の貫 通孔を有する多孔質構造を有し、かつ該構造表面に直径数 nm、例えば直径 1一 15 Onm、好ましくは直径 1一 lOOnmの細孔を有する多孔質固定ィ匕素子である。また、 使用する機能性物質と被覆する薄膜の性質により異なってくるが、該多孔質固定ィ匕 素子の空隙率は 40— 95%、特に 50— 90%であるのが好ましぐ該多孔質構造によ る表面積 ίま lg当たり 50— 1, 000m2,特に 100— 800m2であるの力好まし!/ヽ。 It is preferable that the porous immobilization element of the present invention has voids through which the solvent easily passes, and fine irregularities that increase the surface area of the particles or walls constituting the voids. Particularly preferred is a porous structure having several m, for example 0.1-10 m, preferably 0.3-through holes, which penetrate the solvent, and having a diameter of several nm on the surface of the structure. For example, it is a porous fixing element having pores with a diameter of 11 15 Onm, preferably 11 10 nm. The porosity of the porous fixed element is preferably 40 to 95%, and more preferably 50 to 90%, although it depends on the functional substance used and the properties of the thin film to be coated. surface area ί or lg per 50- 1 that by the structure, 000m 2, particularly preferably a force of some in the 100- 800m 2! /ヽ.

[0021] 該多孔質固定ィ匕素子は、図 1の写真に示すように溶媒を透過する数/ z mの空隙を 有する多孔性構造を有し、さらに拡大すると図 2に示すように、多孔性構造の表面に 極めて多くの直径数 nmの窪み (nm細孔)を有する。したがって、該多孔質固定化素 子の表面積は極めて大きぐ該表面上を機能性物質を含む薄膜で被覆することによ り、機能性物質による反応を効率的に行うことができる。  [0021] The porous fixing element has a porous structure having voids of several zms permeating the solvent as shown in the photograph of FIG. 1, and when further enlarged, as shown in FIG. The surface of the structure has a very large number of depressions (nm pores) several nm in diameter. Therefore, the surface area of the porous immobilization element is extremely large, and the reaction with the functional substance can be performed efficiently by coating the surface with a thin film containing the functional substance.

該多孔質固定ィ匕素子は、加水分解性の官能基を有する有機金属化合物、及び Z 又は、少なくとも 1個の金属'炭素結合を介して結合した非加水分解性の有機官能基 と加水分解性の官能基とを含む有機金属化合物を加水分解し、かつ重合して得られ た重合体を含むものである。  The porous immobilizing element comprises an organometallic compound having a hydrolyzable functional group, and a non-hydrolyzable organic functional group bonded through Z or at least one metal'carbon bond. And a polymer obtained by hydrolyzing and polymerizing an organometallic compound having a functional group of

[0022] 該有機金属化合物には、ケィ素、チタン、ジルコニウム、及びアルミニウム力 なる 群から選ばれる金属を含む有機金属化合物があり、特にケィ素を含む有機金属化合 物が好ましい。本発明では、これらを単独で、又は組み合わせて用いることができる。 該加水分解性の官能基を有する有機金属化合物の例を挙げると、下記一般式(1) で表される金属アルコキシドがある。また、少なくとも 1個の金属 炭素結合を介して 結合した非加水分解性の有機官能基と加水分解性の官能基とを含む有機金属化合 物の例を挙げると、一般式(2)—(4)で表される金属アルコキシドがある。これらの金 属アルコキシドを単独で、又は組み合わせて使用することができる。 [0022] The organometallic compound includes an organometallic compound containing a metal selected from the group consisting of silicon, titanium, zirconium, and aluminum, and an organometallic compound containing silicon is particularly preferable. In the present invention, these can be used alone or in combination. Examples of the organometallic compound having a hydrolyzable functional group include a metal alkoxide represented by the following general formula (1). An example of an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal carbon bond is represented by the general formula (2)-(4 )). These metal alkoxides can be used alone or in combination.

[0023] [化 1]  [0023] [Formula 1]

Figure imgf000009_0001
Figure imgf000009_0001

[0024] [化 2] [0024] [Formula 2]

Figure imgf000009_0002
Figure imgf000009_0002

[0025] [化 3] [0025]

Figure imgf000009_0003
[0026] [化 4]
Figure imgf000009_0003
[0026] [Formula 4]

Figure imgf000010_0001
Figure imgf000010_0001

[0027] これらの式中、 R— Rは、メチル基、ェチル基、プロピル基、ァリル基、アルキルメ In these formulas, R—R represents a methyl group, an ethyl group, a propyl group, an aryl group,

1 4  14

タクリル基、ァリルメタクリル基、アルキルスルホ-ル基、ァリルスルホ -ル基、ァリルァ ミノ基、又はアルキルアミノ基などを表す。  It represents a acryl group, an aryl methacryl group, an alkyl sulfol group, an aryl sulfol group, an aryl amino group, an alkyl amino group, or the like.

本発明の多孔質固定化素子は、特にテトラメトキシシランの重合体、テトラメトキシシ ランとメチルトリメトキシシランとの共重合体、又はテトラエトキシシラン、メタクリル酸 3— トリメキシシリルプロピルの重合体で構成するのが好ま 、。前記多孔質固定化素子 は、次のように作製することができる。  The porous immobilization element of the present invention is preferably a polymer of tetramethoxysilane, a copolymer of tetramethoxysilane and methyltrimethoxysilane, or a polymer of tetraethoxysilane or 3-trimethoxysilylpropyl methacrylate. Preferred to make up. The porous fixing element can be manufactured as follows.

[0028] 先に記載した、加水分解性の官能基を有する有機金属化合物、又は少なくとも 1個 の金属'炭素結合を介して結合した非加水分解性の有機官能基と加水分解性の官 能基とを含む有機金属化合物 (以下、有機金属化合物という。)を加水分解する。 該加水分解には、塩酸、硫酸、トシル酸、陽イオン交換榭脂等の酸触媒、アンモ- ァ、トリェチルァミン、水酸化ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム、陰イオン 交換榭脂等の塩基性触媒等を用いて、水;メタノール、エタノール、プロパノール、ブ タノール等のアルコール類;ァセトニトリル、テトラヒドロフラン、 1, 4 ジォキサン等の 有機溶媒;又はこれらの混合溶媒中で重合を行う。反応温度は 0— 120°C、好ましく は 0— 80°Cとし、反応時間は 1分一 200時間、好ましくは 10分間一 24時間とする。  [0028] The above-mentioned organometallic compound having a hydrolyzable functional group, or a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal'carbon bond. (Hereinafter referred to as an organometallic compound). For the hydrolysis, acid catalysts such as hydrochloric acid, sulfuric acid, tosylic acid, and cation exchange resin, and basic catalysts such as ammonium, triethylamine, sodium hydroxide, sodium carbonate, sodium hydrogen carbonate, and anion exchange resin. Polymerization is carried out in water; alcohols such as methanol, ethanol, propanol and butanol; organic solvents such as acetonitrile, tetrahydrofuran and 1,4-dioxane; or a mixed solvent thereof. The reaction temperature is 0 to 120 ° C, preferably 0 to 80 ° C, and the reaction time is 1 minute to 200 hours, preferably 10 minutes to 24 hours.

[0029] 次に、該加水分解溶液の一部にゲル化の過程で相分離を引き起こす溶媒を混合 する。相分離を起こす溶媒であれば特に制限なく使用できるが、例を挙げると、トル ェン、クロ口ホルム、ポリエチレングリコール溶液などがある。該混合液を熱重合、光 重合により重合させる。光重合の際には、ラジカル発生剤、例えばィルガキュア 1800 ( Irgacure 1800 (日本チバ ·ガイギ一社) )などを共存させる。 該重合の後、得られた反応物を水もしくはメタノールなどの有機溶媒で洗浄し、乾 燥させて多孔質固定ィ匕素子を得る。キヤビラリ一、又はカラム管内に該固定ィ匕素子を 形成する場合は、キヤビラリ一又はカラム管内で重合反応をおこなう。また、この場合 の重合度は、多孔質固定ィ匕素子の大きさにより適宜変化させることが出来る。 Next, a solvent that causes phase separation in the course of gelation is mixed with a part of the hydrolysis solution. Any solvent that causes phase separation can be used without any particular limitation. Examples thereof include toluene, chloroform, and a polyethylene glycol solution. The mixture is polymerized by thermal polymerization or photopolymerization. At the time of photopolymerization, a radical generator, for example, Irgacure 1800 (Nippon Ciba Geigy Co., Ltd.) is coexisted. After the polymerization, the obtained reaction product is washed with an organic solvent such as water or methanol, and dried to obtain a porous fixed device. When forming the fixed element in a capillary or a column tube, a polymerization reaction is carried out in the capillary or the column tube. Further, the degree of polymerization in this case can be appropriately changed depending on the size of the porous fixing element.

[0030] 最後に、溶媒を気化させることにより乾燥ゲルの多孔質固定ィ匕素子とする。該乾燥 は、 30— 80°Cで数時間一数十時間放置して行い、その後、 200— 800°C程度でカロ 熱し、共存有機物を取り除くのが好ましい。  Finally, the solvent is vaporized to obtain a dried gel porous fixing element. The drying is preferably carried out at 30 to 80 ° C. for several hours to several tens of hours, and thereafter, it is preferably heated to about 200 to 800 ° C. to remove coexisting organic substances.

なお、本発明の多孔質固定化素子を、キヤビラリ一、又はカラム菅の全体、又は一 部に、或いはマイクロチップのアレイに形成して、機能性物質を被覆して使用すること ができる。すなわち、前記キヤビラリ一等の内部で、前記加水分解性の官能基を有す る有機金属化合物等を適当な条件で重合させ、溶媒を透過する数 mの貫通孔を 有する多孔質構造を有し、かつ該構造表面に直径数 nmの細孔を有する多孔質固 定化素子を形成し、続いて、該固定ィ匕素子に機能性物質を被覆するのである。これ により、該機能性物質に基づく生化学、又は化学反応を行い、かつ生成物の分離を 容易に行うことができ、続く分析、又は回収行程を連続的に行うことができる。  The porous immobilization element of the present invention can be used by covering the entirety or part of a cavity or a column tube, or forming an array of microchips, and coating a functional substance. That is, the organic metal compound having a hydrolyzable functional group or the like is polymerized under appropriate conditions in the inside of the capillaries and the like, and has a porous structure having through holes of several meters that allow the solvent to pass through. In addition, a porous fixed element having pores with a diameter of several nm is formed on the surface of the structure, and then, the functional element is coated on the fixed element. Thus, biochemical or chemical reaction based on the functional substance can be performed, and the product can be easily separated, and the subsequent analysis or recovery process can be continuously performed.

[0031] 本発明では、市販されている電気泳動用、又はガスクロマトグラフィー用のキヤビラ リーを特に制限なく使用できる。該キヤビラリ一の寸法は、内径が 1一 200 /ζ πι、特に 50— 100 mとするのが好ましぐ長さは、 1cm— 10m、特に 10cm— lmとするの が好ましい。長さ力 1cm未満の場合、十分な分離が行われず、また 10mを超える 場合、分離に長時間が必要となるため好ましくない。また、カラム管は、ガラス、ステン レス、プラスチック、又はフッ素榭脂(例えば、テフロン (登録商標))のものを特に制限 なく使用できる。  [0031] In the present invention, commercially available cavities for electrophoresis or gas chromatography can be used without any particular limitation. The dimensions of the capillaries are preferably 1/200 / 内径 πι, particularly 50-100 m, and the length is preferably 1 cm-10 m, particularly 10 cm-lm. If the length force is less than 1 cm, sufficient separation is not performed, and if it exceeds 10 m, it takes a long time for separation, which is not preferable. The column tube may be made of glass, stainless steel, plastic, or fluorine resin (for example, Teflon (registered trademark)) without any particular limitation.

また、基板に形成された円筒形などの凹部の、平坦な又は多孔質部を設けた内壁 面、すなわちアツセィプレートのゥエル内壁を前記薄膜の固定ィ匕素子として使用する こと力 Sできる。該ァッセィプレートには、 1枚のプレートに各 6、 12、 24, 48、 96、 386 、又は 1536個等のゥヱル形成したものが存在し、これらのゥエルの内壁を固定化素 子として利用することができる。なお、必要に応じこれらの内壁表面上で、前記加水 分解性の官能基を有する有機金属化合物等を適当な条件で重合させ、又は別に作 成した多孔質固定ィ匕素子の粒子を固定して多孔質固定ィ匕素子として用いることもで きる。 Further, the inner wall surface of the concave portion such as a cylindrical shape formed on the substrate, which is provided with a flat or porous portion, that is, the inner wall of the assemble plate can be used as a fixing element for the thin film. The assay plate contains 6, 12, 24, 48, 96, 386, or 1536 pills formed on one plate, and the inner wall of these pills is used as an immobilization element. Can be. If necessary, the above-mentioned organometallic compound having a hydrolyzable functional group is polymerized under appropriate conditions on these inner wall surfaces, or separately prepared. The particles of the formed porous fixing element can be fixed and used as the porous fixing element.

[0032] (機能性物質)  [0032] (Functional substance)

本明細書における用語「機能性物質」とは、化学的、生物化学的、又は生物学的な 反応を起こす、又は触媒する物質をいい、酵素、ホルモン、抗体などの生理活性物 質のみならず、広範囲の活性物質を含む。本発明の網状構造の薄膜に固定して利 用できるものであれば、特に制限なく該機能性物質として用いることができる。  As used herein, the term “functional substance” refers to a substance that causes or catalyzes a chemical, biochemical, or biological reaction, and includes not only physiologically active substances such as enzymes, hormones, and antibodies, but also , Containing a wide range of active substances. As long as it can be used by being fixed to the thin film having a network structure of the present invention, it can be used as the functional substance without any particular limitation.

該機能性物質の例を挙げると、 P450、ダルクロニルトランスフェラーゼなどの代謝 酵素、トリプシン、ペプシンなどのタンパク質加水分解酵素等のタンパク質、核酸、脂 質、糖、薬物等の生理活性性質、金属触媒などの合成機能性物質、フラーレン、力 一ボンナノチューブ、ポリ口タキサン、カテナンなどの特異的な形状の化合物などが ある。なお、該薬物の例を挙げるとアスピリン、モルフイネ、テトロドトキシンなどがある 。本発明では、特に不安定で、不活性ィ匕し易い各種代謝酵素などは、ミクロノームに 包含した形態で薄膜に固定して用いることができる。  Examples of such functional substances include metabolic enzymes such as P450 and dalcuronyltransferase; proteins such as protein hydrolases such as trypsin and pepsin; nucleic acids, fats, sugars, physiologically active properties such as drugs, and metal catalysts. Synthetic functional materials, such as, fullerene, carbon nanotubes, polymorphic taxanes, catenane, and other specific shaped compounds. Examples of the drug include aspirin, morphine, tetrodotoxin and the like. In the present invention, various metabolic enzymes, which are particularly unstable and easily deactivated, can be used by immobilizing them on a thin film in a form included in a micronome.

[0033] (網状構造を有する薄膜の形成)  (Formation of Thin Film with Network Structure)

まず、機能性物質を含有する有機金属化合物のゾル溶液を調製する。加水分解性 の官能基を有する有機金属化合物、又は少なくとも 1個の金属'炭素結合を介して結 合した非加水分解性の有機官能基と加水分解性の官能基とを含む有機金属化合物 を加水分解する。  First, a sol solution of an organometallic compound containing a functional substance is prepared. Hydrolyzing an organometallic compound having a hydrolyzable functional group, or an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal 'carbon bond Decompose.

該加水分解には、塩酸、硫酸、トシル酸、陽イオン交換榭脂等の酸触媒、アンモ- ァ、トリェチルァミン、水酸化ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム、陰イオン 交換榭脂等の塩基性触媒等を用いて、水;メタノール、エタノール、プロパノール、ブ タノール等のアルコール類;ァセトニトリル、テトラヒドロフラン、 1, 4 ジォキサン等の 有機溶媒;又はこれらの混合溶媒中で行う。前記有機金属化合物と溶媒のモル比は 、使用する有機金属化合物、溶媒などで変化するが、 3 : 1-1 : 10,特に 1: 1一 1 :4 とするのが好ましい。また反応温度は 0— 120°C、好ましくは、 0— 80°Cとし、反応時 間は 1分一 200時間、好ましくは 10分間一 24時間とする。  For the hydrolysis, acid catalysts such as hydrochloric acid, sulfuric acid, tosylic acid, and cation exchange resin, and basic catalysts such as ammonium, triethylamine, sodium hydroxide, sodium carbonate, sodium hydrogen carbonate, and anion exchange resin. Water; alcohols such as methanol, ethanol, propanol and butanol; organic solvents such as acetonitrile, tetrahydrofuran and 1,4-dioxane; or a mixed solvent thereof. The molar ratio between the organometallic compound and the solvent varies depending on the organometallic compound used, the solvent, and the like, but is preferably 3: 1 to 1:10, particularly preferably 1: 1 to 1: 4. The reaction temperature is 0 to 120 ° C, preferably 0 to 80 ° C, and the reaction time is 1 minute to 200 hours, preferably 10 minutes to 24 hours.

[0034] 次に、該加水分解溶液と、機能性物質を含有する溶液とを混合する。該混合液を ゾル溶液と称する。該機能性物質が酵素など生体物質の場合は、緩衝液に溶解す ることが好ましい。該機能性物質の濃度、溶液の pH、緩衝液の場合は塩濃度などを 適宜最適化することにより、ゲル化速度、ゲルの微細構造などを変化させることが出 来る。 Next, the hydrolysis solution is mixed with a solution containing a functional substance. The mixture It is called a sol solution. When the functional substance is a biological substance such as an enzyme, it is preferably dissolved in a buffer solution. By appropriately optimizing the concentration of the functional substance, the pH of the solution, and the salt concentration in the case of a buffer, the gelation rate, the microstructure of the gel, and the like can be changed.

また、図 8に示すように、ゲルは pHが酸性側であると空隙の大きな鎖状構造に、 pH が塩基性側であると分岐が多 、網状構造になる。  Further, as shown in FIG. 8, the gel has a chain structure with large voids when the pH is on the acidic side, and has a network with many branches when the pH is on the basic side.

[0035] 例えば、機能性物質力タンパク質力もなる生理活性物質の場合、溶液中の濃度を 10— 5— IMolZl (モル Zリットル)、好ましくは 10— 4— 10—MolZlとし、該溶液の pH は 2— 10、特に 4一 8とするのが好ましぐかつ塩濃度を 0. 001— 1ΜοΐΖΐ、特に 0. 01—0. 2MolZlとするのが好ましい。 [0035] For example, when the functional substance force proteins force becomes physiologically active substance, the concentration in solution 10- 5 - IMolZl (mole Z l), preferably 10 4 - and 10-MolZl, pH of the solution It is preferred to be 2-10, especially 418, and the salt concentration is preferably 0.001-1-1, particularly 0.01-0.2MolZl.

続いて、該ゾル溶液がゲルィ匕する前に、前記多孔質固定化素子を該ゾル溶液に浸 漬し、該多孔質固定ィ匕素子力も余分なゾル溶液を取り除き、乾燥させることにより、該 多孔質固定ィ匕素子の表面上に機能性物質を含有する薄膜を塗布することができる。 乾燥を行う際の温度は、高いほど乾燥が早く進むが、機能性物質が生理活性物質で ある場合、変性又は活性低下を防止するため 0°Cから 30°C、好ましくは 0°C— 20°C、 さらに好ましくは 0°C— 10°Cとする。  Subsequently, before the sol solution gelates, the porous immobilization element is immersed in the sol solution, the excess of the porous immobilization element force is also removed, and the porous immobilization element is removed by drying. A thin film containing a functional substance can be applied on the surface of the quality fixing device. The higher the drying temperature, the faster the drying proceeds. However, when the functional substance is a physiologically active substance, it is 0 to 30 ° C, preferably 0 to 20 ° C to prevent denaturation or decrease in activity. ° C, more preferably 0 ° C-10 ° C.

[0036] 機能性物質を含む網状構造の薄膜を被覆した多孔質固定ィ匕素子は、測定ごとに アツセィプレートから取り出し再利用することも可能である力 直接、アツセィプレート に結合させ、活性測定と再生を繰り返し行うこともできる。 [0036] The porous fixed element coated with a thin film having a network structure containing a functional substance can be taken out of the assay plate and reused for each measurement. Measurement and regeneration can be repeated.

なお、該薄膜作成時のゾルーゲル反応をアルコキシシランの重合反応に基づき説 明すると、図 4に示すように、所定のアルコキシシランを加水分解し、生成したモノマ 一を重縮合することにより所望のゲルを形成するものであり、図 5に示すように、該モ ノマーが重合し、網状構造が形成される過程で機能性物質が、薄膜の網状構造に固 定される。  The sol-gel reaction at the time of forming the thin film will be described based on a polymerization reaction of alkoxysilane. As shown in FIG. 4, a desired gel is obtained by hydrolyzing a predetermined alkoxysilane and polycondensing a produced monomer. As shown in FIG. 5, the functional substance is fixed to the thin-film network structure in the process in which the monomer is polymerized to form a network structure.

[0037] これを拡大して描くと図 3に示すように、多孔質固定化素子の窪み (nm細孔)の表 面を、厚さ 1一 10, OOOnmの薄膜が覆っており、さらに部分的に拡大すると図 3の A に示すように、該薄膜は 0. 1— 50nmの空隙を有する網状構造の中に機能性物質を 捉えて固定している。 また、本発明で用いるミクロソームは、常法によりラット肝臓など力も精製できる。ま た、 P450やダルク口-ルトランスフェラーゼを導入したミクロノームが市販されている( 第一化学薬品)。 [0037] When this is enlarged and drawn, as shown in Fig. 3, the surface of the depression (nm pore) of the porous immobilization element is covered with a thin film of 110, 10 nm and a thickness of OOOnm. As shown in FIG. 3A, the thin film captures and fixes the functional substance in a network structure having voids of 0.1 to 50 nm. In addition, the microsomes used in the present invention can purify the power of rat liver and the like by a conventional method. In addition, a micronome in which P450 and DARC-transferase are introduced is commercially available (Daiichi Pure Chemicals).

[0038] (本発明の固定ィ匕素子の使用の態様) (Embodiment of Use of Fixed Device of the Present Invention)

ゥエルを有するアツセィプレートを使用する場合  When using an attachment plate with a hole

アツセィプレートのゥエル内に機能性物質を薄膜で被覆した多孔質固定ィ匕素子を 入れ、又は固定し、該機能性物質による生化学あるいは化学反応を行う。また、該ゥ エルの内壁を固定ィ匕素子として、機能性物質を薄膜で被覆することもできる。  A porous fixing element coated with a thin film of a functional substance is put in or fixed in a well of an atsie plate, and a biochemical or chemical reaction is performed by the functional substance. In addition, a functional substance can be coated with a thin film using the inner wall of the well as a fixing element.

該ァッセィプレートとしては、 1枚のプレートに各 6、 12、 24、 48、 96、 386、又は 153 6個等のゥエルを有するものが市販されており、作製時に多孔質固定ィ匕素子の大きさ を適宜変えて、これらのゥエルに適した大きさとする。所定の反応を行った後、活性測 定は、プレートリーダーなどを用いて行うことができる。  As the assay plate, a plate having 6, 12, 24, 48, 96, 386, or 1536 beads on a single plate is commercially available. Is changed appropriately to make the size suitable for these wells. After performing a predetermined reaction, the activity can be measured using a plate reader or the like.

実施例  Example

[0039] (実施例 1) (Example 1)

ペプシン固定ィヒカラムの製造と性能試験  Production and performance test of pepsin immobilized Eich column

一方の端部に、長さ 5cmの、ペプシン (和光純薬)を含む薄膜を被覆した多孔質固 定化素子を有するフューズドシリカキヤビラリ一(内径 75 μ m、長さ lm、 Polymicro Technologies INC.製)を用いた。  On one end, a fused silica cavity with a 5 cm long porous immobilization element coated with a thin film containing pepsin (Wako Pure Chemicals) (75 μm id, lm length, Polymicro Technologies INC.).

本実施例で用いたペプシン固定ィ匕カラムを次の手順で製造した。メタクリル酸 3—ト リメトキシシリルプロピル(MTMSP) (東京化成) 750 μ 1に、水 225 μ 1及び 1Mの HC1 を 22. 5 μ 1加え、室温で 30分間撹拌を行った。該溶液 30 μ 1にトルエン 170 μ 1をカロ え再び 30分間撹拌した後、ィルガキュア 18OO (Irgacurel800 (日本チノ 'ガイギ一社 ) ) 8. 9mgを加え、更に 2. 5時間以上撹拌した。固定ィ匕素子を作製する部位 (キヤピ ラリーの一端約 5cm)以外をポリイミドコーティングで遮光した内径 75 μ m、長さ 40c mのキヤピラリー内に該溶液を充填し、約 20分間 UV照射を行い、光重合反応により 固定ィ匕素子をキヤピラリー内に作製した。該 UV照射には、 RPR— 100光化学反応器 (photochemical reactor, Ultraviolet Company, Branford, CT, U¾A)を用 ヽァこ。メタノ 一ルで未反応溶液を除去後、 110°Cのオーブン中にー晚静置し、乾燥させた。 [0040] テトラメトキシシラン(TMOS) (東京化成) 761 μ 1に水 169 μ 1、 0. 04Μの HC1を 11 μ 1加え、室温で 20分間攪拌を行った。該溶液 20 μ 1に 25% (w/v)ペプシンを含む 1 50mMリン酸緩衝液 (pH5. 5) 60 1をカロえ混合した後、該ゾル溶液を固定ィ匕素子 のみが浸漬するようにシリンジでキヤピラリー内に導入した。 4°Cで 5分間放置後、キ ャピラリー力ゝら該混合液を追い出し、 4°Cで 2日以上静置することにより、固定化素子 上にペプシンを包含した薄膜を作製した。 The pepsin-fixed column used in this example was manufactured by the following procedure. To 750 μl of 3-trimethoxysilylpropyl methacrylate (MTMSP) (Tokyo Kasei), 225 μl of water and 22.5 μl of 1M HC1 were added, and the mixture was stirred at room temperature for 30 minutes. After adding 170 μl of toluene to 30 μl of the solution and stirring again for 30 minutes, 8.9 mg of Irgacure 18OO (Irgacurel 800 (Nippon Chino, Geigy One)) was added, and the mixture was further stirred for 2.5 hours or more. Filling the solution into a capillary with an inner diameter of 75 μm and a length of 40 cm, which is light-shielded with a polyimide coating except for the part where the fixed ridge element is to be made (one end of the capillary is about 5 cm), and performs UV irradiation for about 20 minutes, A fixed polymer element was prepared in a capillary by a photopolymerization reaction. For the UV irradiation, use a RPR-100 photochemical reactor (Ultraviolet Company, Branford, CT, U, A). After removing the unreacted solution with methanol, the mixture was allowed to stand in an oven at 110 ° C. and dried. [0040] Tetramethoxysilane (TMOS) (Tokyo Kasei Co., Ltd.) was added with 169 µl of water and 11 µl of 0.01% HC1 to 761 µl, and the mixture was stirred at room temperature for 20 minutes. After mixing 150 μl of 150 mM phosphate buffer (pH 5.5) 601 containing 25% (w / v) pepsin in 20 μl of the solution, the sol solution was immersed so that only the immobilizing element was immersed. It was introduced into the capillary with a syringe. After leaving at 4 ° C for 5 minutes, the mixed solution was expelled from the capillary force and allowed to stand at 4 ° C for 2 days or more to prepare a thin film containing pepsin on the immobilized element.

電気泳動装置には Agilent社製の3 DCE systemを、質量分析装置には MSD mass spectrometerを用いた。また泳動液には、 500mMのギ酸溶液(和光純薬)を用い、 分析時には 15kVの電位差をキヤビラリ一の両端に与え、さらに多孔質固定ィ匕素子の ある端部から 50mbarの圧力で送液を行った。試料には、インシュリン 鎖( The electrophoresis apparatus 3 D CE system manufactured by Agilent Technologies, the mass spectrometer using MSD mass spectrometer. In addition, a 500 mM formic acid solution (Wako Pure Chemical Industries) was used as the electrophoresis solution. A 15 kV potential difference was applied to both ends of the capillary at the time of analysis, and the liquid was sent at a pressure of 50 mbar from one end of the porous fixed element. went. The sample contains insulin chains (

Sigma- Aldrich)ゃリゾチーム(Sigma- Aldrich)を用い、キヤビラリ一の両端に 20秒間 2 OkVの電位差を生じさせることで注入した。  Sigma-Aldrich) lysozyme (Sigma-Aldrich) was used to inject a voltage of 2 OkV across the ends of the capillary for 20 seconds.

[0041] ペプシンを含む薄膜を被覆した多孔質固定ィ匕素子により、注入された試料は消化 され、生成したペプチドフラグメントを電気泳動により分離し、直接質量分析装置に導 入して、検出した。検出されたペプチドフラグメントは、試料をペプシンで酵素消化し た時に生じると考えられる酵素特異的な切断が行われていた。また生成したペプチド 断片を用いタンパク質の同定ソフトである Protein Prospector 4.0.5 (the University of California San Francisco, http://prospector.ucsf.edu)を用いることで、試料のタンノ ク質を同定した。該検出工程を 30回連続して行い分析しても、ペプシンの活性は保 持されていた。 The injected sample was digested by a porous immobilizing element coated with a thin film containing pepsin, and the generated peptide fragments were separated by electrophoresis and directly introduced into a mass spectrometer for detection. The detected peptide fragment had undergone an enzyme-specific cleavage that would occur when the sample was digested with pepsin. The protein of the sample was identified by using Protein Prospector 4.0.5 (the University of California, San Francisco, http://prospector.ucsf.edu) which is a protein identification software using the generated peptide fragment. The activity of pepsin was maintained even when the detection step was performed 30 times in succession and analyzed.

[0042] (実施例 2) (Example 2)

トリプシンを含む薄膜を被覆した多孔質固定ィ匕素子の製造と使用  Manufacture and use of porous immobilization device coated with a thin film containing trypsin

96穴アツセィプレート(Millipore製)のゥエルの大きさに合うトリプシン(  Trypsin to fit the size of a 96-well Atsushi plate (Millipore)

Sigma- Aldrich社)固定化素子を調製し、実験に用いた。  (Sigma-Aldrich) An immobilized element was prepared and used for the experiment.

本実施例で用いたトリプシン薄膜固定ィ匕素子を次の手順で製造した。テトラメトキシ シラン(TMOS) (東京化成) lmlにポリエチレングリコール 0. 27gを溶解した 0. 01M 酢酸 2. 5mlをカ卩え、 0°Cで 45分間撹拌した。該溶液を 40°Cで 1晚放置し重合反応さ せ、水で洗浄後、 目的の形状に成型し、 0. 01Mアンモニア水で 120°C、 3時間処理 後、再び水で洗浄し、 40°Cで 3日間乾燥させた。該重合体を 600°Cで 2. 5時間加熱 し、多孔質固定ィ匕素子を作製した。 The trypsin thin-film fixed device used in this example was manufactured by the following procedure. 2.5 ml of polyethylene glycol dissolved in 1 ml of tetramethoxysilane (TMOS) (Tokyo Kasei) was added with 2.5 ml of 0.01M acetic acid and stirred at 0 ° C for 45 minutes. The solution was left standing at 40 ° C for 1 晚 to carry out the polymerization reaction, washed with water, molded into the desired shape, and treated with 0.01M ammonia water at 120 ° C for 3 hours Thereafter, it was washed again with water and dried at 40 ° C. for 3 days. The polymer was heated at 600 ° C. for 2.5 hours to produce a porous fixed device.

[0043] テトラメトキシシラン(TMOS) (東京化成) 761 μ 1に水 169 μ 1、 0. 04Μの HC1を 11 μ 1加え、室温で 20分間攪拌を行った。該溶液 20 μ 1に 5% (w/v)トリプシンを含む 5 OmMトリス塩酸緩衝液 (pH7. 0) 120 1をカ卩ぇ混合した後、該ゾル溶液に多孔質固 定化素子を 5分間浸潰し、多孔質固定化素子を取り出し、 4°Cで 2— 3日間静置する ことにより、多孔質固定ィ匕素子表面にトリプシン包含薄膜を形成した。  To 761 μl of tetramethoxysilane (TMOS) (Tokyo Kasei), 169 μl of water and 11 μl of 0.01% of HC1 were added, and the mixture was stirred at room temperature for 20 minutes. 20 μl of the solution was mixed with 5 OmM Tris-HCl buffer (pH 7.0) 1201 containing 5% (w / v) trypsin in 120 μl, followed by mixing the sol solution with the porous immobilization element for 5 minutes. The porous immobilized device was immersed, taken out, and allowed to stand at 4 ° C. for 2-3 days to form a trypsin-containing thin film on the surface of the porous immobilized device.

固定ィ匕素子に固定されたトリプシンの活性測定には、マルチラベルカウンタ 1420 ARVOsx (Wallac製)を用い、試料には Να -ベンゾィルアルギ-ン p--トロア-リド(N — benzoy卜 arginine p— nitroaniiide (BAPNA) (Sigma社) )と尸ゾカセイン、 azocasein, Sigma社)とを用いた。 lmg/ μ 1の ΒΑΡΝΑ30 μ 1と 62. 5mMの Tris/HCl緩衝液 ( pH7. 5) 120 1との混合溶液の入ったゥエルにトリプシンを固定ィ匕した多孔質固定 化素子を加え、 37°Cで 15分間攪拌することで酵素反応を行った。該多孔質固定ィ匕 素子を取り除いた後、吸収強度 (405nm)の変化を測定することで、酵素活性を測定 した。ァゾカゼインを用いた実験についても同様な手法を用い、 355nmの吸収強度 の変化により活性を測定した。 Measuring the activity of trypsin which is fixed to the fixed I匕素Ko is multilabel counter 1420 with ARVOsx (manufactured by Wallac), in a sample New alpha - Benzoiruarugi - down p-- trois - Lido (N - benzoy Bok arginine p- nitroaniiide (BAPNA) (Sigma)) and zocasein (azocasein, Sigma) were used. lmg / μ1 ΒΑΡΝΑ30 μ1 and 62.5 mM Tris / HCl buffer (pH 7.5) 1201 The enzyme reaction was performed by stirring at C for 15 minutes. After removing the porous immobilizing element, the enzyme activity was measured by measuring the change in absorption intensity (405 nm). In an experiment using azocasein, the activity was measured by a change in the absorption intensity at 355 nm using the same method.

[0044] 図 6に示すように、該活性を 20回以上測定しても、トリプシンの活性は低下せず、 5 0回連続して分析を行っても必要な活性を維持していた。また、 4°Cで保存すると 3ケ 月以上、トリプシンの活性は変化しな力つた。  As shown in FIG. 6, even if the activity was measured 20 times or more, the activity of trypsin did not decrease, and the required activity was maintained even after 50 consecutive analyzes. When stored at 4 ° C, the activity of trypsin remained unchanged for more than 3 months.

[0045] (実施例 3)  (Example 3)

P450を含有するミクロソームを包含した薄膜を被覆した多孔質固定ィ匕素子の製造 とその使用例  Production of porous immobilization device coated with a thin film containing microsomes containing P450 and examples of its use

まず、実施例 2と同じ手順で固定ィ匕素子を製造した。次いで、テトラメトキシシラン( TMOS) (東京ィ匕成) 761 μ 1に水 169 μ 1、及び 0. 04Μの HC1を 11 μ 1カロえ、室温で 20分間攪拌を行った。該溶液 20 μ 1に Ρ450を含むミクロソーム (第一化学薬品)溶 液 (タンパク質濃度 2. 75mgZml) 100 1を加え攪拌した混合液に、多孔質固定ィ匕 素子を浸し、直ちに取り出し、 4°Cで 2日以上乾燥させることで多孔質固定ィ匕素子表 面に P450含有薄膜を作製した。 [0046] 多孔質固定化素子は、溶媒が透過できる 0. 3-6 μ mの貫通孔を有し、さらに表面 積を大きくする 1一 lOOnmの細孔を有することから、 P450の反応効率を高めること が期待された。 First, a fixing device was manufactured in the same procedure as in Example 2. Next, 171 μl of water and 11 μl of 0.01% of HC1 were added to 761 μl of tetramethoxysilane (TMOS) (Tokyo Danisei), and the mixture was stirred at room temperature for 20 minutes. A microsomal (Daiichi Pure Chemicals) solution containing Ρ450 in 20 μl of the solution (protein concentration: 2.75 mgZml) 100 1 was added and stirred, and the porous immobilizing device was immersed in the mixed solution. After drying for 2 days or more, a P450-containing thin film was formed on the surface of the porous fixed device. The porous immobilization element has a through hole of 0.3 to 6 μm through which a solvent can pass, and further has a pore size of 110 nm to increase the surface area. It was expected to increase.

一方、ミクロノームのコーティングには、アルコキシシランの加水分解及び重合に伴 い、その架橋構造内に緩和な条件でミクロソームを包含し、固定ィ匕する手段を用いた ハイスループットスクリーニングシステムに適応させるため、反応は 96穴マイクロプ レートを用い、ゥエルに入る大きさになるよう多孔質固定ィ匕素子を作製した。 96穴マイ クロプレートのゥエルに P450を含む薄膜を被覆した多孔質固定ィ匕素子と蛍光性基 質エトキシレゾルフイン溶液を入れ、 37°Cで反応させた。該反応は下記化学式(5)に 示すように起きる。  On the other hand, the coating of the micronome involves the hydrolysis and polymerization of the alkoxysilane, the microsomes are included in the cross-linked structure under mild conditions, and the method is adapted to a high-throughput screening system using a means for immobilization. For the reaction, a 96-well microplate was used, and a porous immobilization element was manufactured so as to have a size that would fit in a well. A porous fixing element coated with a thin film containing P450 and a fluorescent substrate ethoxyresorufin solution were placed in a well of a 96-well microplate and reacted at 37 ° C. The reaction occurs as shown in the following chemical formula (5).

[0047] [化 5] [0047]

Figure imgf000017_0001
Figure imgf000017_0001

[0048] P450の代謝活性は、多孔質固定化素子を取り除き、プレートリーダーを用いて生 成したレゾルフインの生成量を蛍光測定することにより測定した(Ex.550nm, Em.590 nm) 0測定後、該多孔質固定ィ匕素子を 20mMリン酸緩衝液 (pH7. 4)で洗浄し、乾 燥することで、繰り返し 4回、 4日間測定することが可能であった。 [0048] P450 metabolic activity, remove the porous immobilization element, the generation amount of Rezorufuin raw form by using the plate reader was determined by fluorescence measurement (Ex.550nm, Em.590 nm) 0 After the measurement By washing and drying the porous immobilizing element with a 20 mM phosphate buffer (pH 7.4), measurement could be repeated four times for four days.

これまで P450は容易に不活性ィ匕するので固定ィ匕して利用できず、また、 P450力 S 代謝活性の測定を妨げるため、代謝物を P450から分離しなければならな力つた。こ れに対し、本発明で P450を含む薄膜で被覆した多孔質固定ィ匕素子を作成、使用す ることにより、 P450を繰り返し利用できるようになり、測定すべき代謝物を P450から 分離する必要がなくなり、少量の試料、及び試薬で解析が可能になった。すなわち、 本発明により P450を用いた解析が経済的かつ短時間で行えるようになった。  Until now, P450 was easily inactivated and could not be used in a fixed manner, and P450 power S had to be separated from P450 in order to prevent the measurement of S metabolic activity. On the other hand, by preparing and using a porous immobilizing element coated with a thin film containing P450 in the present invention, P450 can be used repeatedly, and it is necessary to separate metabolites to be measured from P450. Disappeared, and analysis became possible with a small amount of sample and reagent. That is, according to the present invention, analysis using P450 can be performed economically and in a short time.

[0049] (実施例 4) P450を含有するミクロソームを包含した薄膜を、直接 96穴マイクロプレートのゥェ ル底部上に形成し、酸化反応を行った使用例 (Example 4) Example in which a thin film containing microsomes containing P450 is formed directly on the bottom of a well of a 96-well microplate and oxidized.

まずテトラメトキシシラン(TMOS) (東京化成) 761 μ 1に 0. 04Μの HC1を 11 μ 1と水 169 1を加え、室温で 20分間攪拌した。該溶液 20 1に Ρ450を含むミクロソーム溶 液 (タンパク質濃度 2. 75π^Ζπι1) 100 /ζ 1をカ卩えて混合した後、予めポリ酢酸ビュル で表面を親水性処理した 96穴マイクロプレートの各ゥエルに 10 μ 1ずつ分注し、 4°C で 2日間以上放置することでゲルィ匕を進行させ、 P450を含む薄膜をゥエル内壁に固 疋した。  First, 11 μl of 0.04% HC1 and water 1691 were added to 761 μl of tetramethoxysilane (TMOS) (Tokyo Kasei) and stirred at room temperature for 20 minutes. After mixing and mixing 100 / ζ1 of a microsomal solution containing Ρ450 (protein concentration 2.75π ^ ιπι1) in the solution 201, each well of a 96-well microplate, the surface of which has been previously hydrophilically treated with polyvinyl acetate, was mixed. 10 μl each, and allowed to stand at 4 ° C. for 2 days or more to allow gelling to proceed, and a thin film containing P450 was fixed on the inner wall of the well.

当該固定化 P450を用いて、実施例 3と同様な方法で薬物の代謝反応を測定した。 図 7に経過時間とレゾルフインの生成量との関係を表すグラフを示す。本方法で作製 した P450固定ィ匕素子においても、繰り返し 13回、 6日間測定が可能であった。  Using the immobilized P450, the metabolic reaction of the drug was measured in the same manner as in Example 3. FIG. 7 is a graph showing the relationship between the elapsed time and the amount of resolufin generated. Also in the case of the P450 fixed device manufactured by this method, measurement was possible repeatedly 13 times for 6 days.

Claims

請求の範囲 The scope of the claims [I] 機能性物質を包含した網目状構造の薄膜で被覆された固定ィヒ素子。  [I] A fixed Ech element coated with a network-like thin film containing a functional substance. [2] 固定ィ匕素子が、多孔質固定ィ匕素子である請求項 1記載の被覆された固定ィ匕素子。  [2] The coated stationary device according to claim 1, wherein the stationary device is a porous stationary device. [3] 該固定化素子が、溶媒を透過する 0. 1— 10 mの貫通孔を有する多孔質構造を 有し、かつ該構造表面に直径 1一 lOOnmの細孔を有する多孔質固定ィ匕素子である[3] The immobilizing element has a porous structure having a through hole of 0.1 to 10 m that is permeable to a solvent, and a porous immobilizing element having pores of 11 lOO nm in diameter on the surface of the structure. Element 、請求項 1記載の被覆された固定化素子。 The coated immobilization element of claim 1. [4] 該固定化素子が、溶媒を透過する 0. 3— 6 μ mの貫通孔を有する多孔質構造を有 する、請求項 3記載の被覆された固定化素子。 [4] The coated immobilization element according to claim 3, wherein the immobilization element has a porous structure having a through-hole of 0.3 to 6 μm that is permeable to a solvent. [5] 該機能性物質が、タンパク質、核酸、脂質、糖、金属触媒、特異的な形状の化合物 力もなる群力 選ばれる少なくとも 1種である、請求項 1記載の被覆された固定ィ匕素 子。 [5] The coated immobilizer according to claim 1, wherein the functional substance is at least one selected from the group consisting of proteins, nucleic acids, lipids, sugars, metal catalysts, and compounds having a specific shape. Child. [6] 該機能性物質が、 P450、ダルク口-ルトランスフェラーゼ、トリプシン、ペプシン、 D NA、 RNA、ペプチド核酸、脂質、糖、金属触媒、フラーレン、カーボンナノチューブ 、ポリ口タキサン、カテナン力もなる群力も選ばれる少なくとも 1種である、請求項 1記 載の被覆された固定ィ匕素子。  [6] The functional substance is P450, darc-transferase, trypsin, pepsin, DNA, RNA, peptide nucleic acid, lipid, sugar, metal catalyst, fullerene, carbon nanotube, poly-mouth taxane, catenane. The coated fixed element according to claim 1, which is at least one selected from the group. [7] 網目状構造の薄膜が、有機金属化合物を主成分とするものである、請求項 1記載 の被覆された固定化素子。  [7] The coated immobilized element according to claim 1, wherein the thin film having a network structure has an organometallic compound as a main component. [8] 機能性物質を含むミクロソームを包含した網目状構造の薄膜で被覆された固定ィ匕 素子。  [8] An immobilization device coated with a network-like thin film containing microsomes containing a functional substance. [9] 固定化素子が、多孔質固定ィ匕素子である請求項 8記載の該被覆された固定ィ匕素 子。  [9] The coated fixing device according to claim 8, wherein the fixing device is a porous fixing device. [10] 該固定化素子が、溶媒を透過する 0. 1— 10 mの貫通孔を有する多孔質構造を 有し、かつ該構造表面に直径 1一 lOOnmの細孔を有する多孔質固定ィ匕素子である 、請求項 8記載の被覆された固定化素子  [10] The immobilization element has a porous structure having a through hole of 0.1 to 10 m that is permeable to a solvent, and a porous immobilization film having pores of 11 lOO nm in diameter on the surface of the structure. The coated immobilized element according to claim 8, which is an element. [II] 該固定化素子が、溶媒を透過する 0. 3— 6 μ mの貫通孔を有する多孔質構造を有 する、請求項 10記載の被覆された固定化素子。  [II] The coated immobilization element according to claim 10, wherein the immobilization element has a porous structure having a through hole of 0.3 to 6 μm that is permeable to a solvent. [12] 該機能性物質が代謝酵素である、請求項 8記載の被覆された固定化素子。  12. The coated immobilized element according to claim 8, wherein the functional substance is a metabolic enzyme. [13] 該機能性物質が、 P450、又はダルクロニルトランスフェラーゼである、請求項 8記 載の被覆された固定ィ匕素子。 [13] The method according to claim 8, wherein the functional substance is P450 or dalcuronyltransferase. The coated fixed dangling element. [14] 網目状構造の薄膜が、有機金属化合物を主成分とするものである、請求項 8記載 の被覆された固定化素子。  14. The coated immobilized element according to claim 8, wherein the thin film having a network structure has an organometallic compound as a main component. [15] 機能性物質を包含した網目状構造の薄膜、又は機能性物質を含むミクロソームを 包含した網目状構造の薄膜で被覆された多孔質固定ィ匕素子が内部に形成されてい るキヤビラリ一、カラム管、又はマイクロチップ。  [15] A capillaries in which a porous immobilization element coated with a thin film having a network structure containing a functional substance or a thin film having a network structure containing microsomes containing a functional substance is formed. Column tube or microchip. [16] 固定化素子上に機能性物質を含む網目状構造の薄膜を被覆する方法であって: 加水分解性の官能基を有する有機金属化合物、又は少なくとも 1個の金属'炭素 結合を介して結合した非加水分解性の有機官能基と加水分解性の官能基とを含む 有機金属化合物を加水分解すること;該加水分解溶液と、機能性物質を含有する溶 液とを混合してゾル溶液を得ること;及び該ゾル溶液に、固定化素子を浸漬し、乾燥 させることにより、該固定ィ匕素子の表面上に薄膜を形成することを含む、前記薄膜の 被覆方法。  [16] A method of coating a network-like thin film containing a functional substance on an immobilization element, comprising: an organometallic compound having a hydrolyzable functional group, or at least one metal'carbon bond Hydrolyzing an organometallic compound containing a bonded non-hydrolyzable organic functional group and a hydrolyzable functional group; mixing the hydrolyzed solution with a solution containing a functional substance to form a sol solution And immersing the immobilized element in the sol solution and drying to form a thin film on the surface of the immobilized element. [17] 乾燥温度が 0°C— 120°Cである、請求項 16記載の薄膜の被覆方法。  17. The method for coating a thin film according to claim 16, wherein the drying temperature is 0 ° C. to 120 ° C. [18] 溶媒を透過する 0. 1— 10 mの貫通孔を有する多孔質構造を有し、かつ該構造 表面に直径 1一 lOOnmの細孔を有する多孔質固定ィ匕素子。  [18] A porous immobilizing element having a porous structure having a through hole of 0.1 to 10 m that is permeable to a solvent, and having pores having a diameter of 11 lOO nm on the surface of the structure. [19] 溶媒を透過する 0. 3-6 μ mの貫通孔を有する多孔質構造を有する、請求項 18記 載の多孔質固定化素子。 [19] The porous immobilization element according to claim 18, having a porous structure having a through-hole of 0.3 to 6 µm, which is permeable to a solvent. [20] 請求項 18、又は 19記載の多孔質固定ィ匕素子の製造方法であって: [20] A method for manufacturing a porous fixed element according to claim 18 or 19, wherein: 加水分解性の官能基を有する有機金属化合物、又は少なくとも 1個の金属'炭素 結合を介して結合した非加水分解性の有機官能基と加水分解性の官能基とを含む 有機金属化合物を加水分解すること;該加水分解溶液にゲル化の過程で相分離を 引き起こす溶媒を混合すること;及び該混合液を熱重合、又は光重合により重合させ ることを含む、前記製造方法。  Hydrolyzes organometallic compounds having a hydrolyzable functional group, or an organometallic compound containing a non-hydrolyzable organic functional group and a hydrolyzable functional group bonded via at least one metal 'carbon bond The method comprising: mixing the hydrolysis solution with a solvent that causes phase separation in the course of gelation; and polymerizing the mixture by thermal polymerization or photopolymerization. [21] 前記加水分解の反応温度が 0— 80°Cであり、かつ反応時間が 10分間一 24時間で ある、請求項 20記載の製造方法。 21. The production method according to claim 20, wherein a reaction temperature of the hydrolysis is 0 to 80 ° C., and a reaction time is 10 minutes to 24 hours. [22] 該加水分解溶液に加える相分離を引き起こす溶媒が、トルエン、クロ口ホルム、又 はポリエチレングリコール溶液力もなる群力 選ばれた少なくとも一種の溶媒である、 Hf 求項 20記載の製造方法。 [22] The solvent which causes phase separation to be added to the hydrolysis solution is at least one selected from the group consisting of toluene, chloroform, and polyethylene glycol solution. Hf The production method according to claim 20.
PCT/JP2004/014055 2003-09-30 2004-09-27 Immobilization element coated with functional-substance-containing thin film and process for producing the same Ceased WO2005033304A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003339280A JP4553568B2 (en) 2003-09-30 2003-09-30 Immobilization element coated with functional substance-containing thin film and method for producing the same
JP2003-339280 2003-09-30

Publications (1)

Publication Number Publication Date
WO2005033304A1 true WO2005033304A1 (en) 2005-04-14

Family

ID=34419150

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/014055 Ceased WO2005033304A1 (en) 2003-09-30 2004-09-27 Immobilization element coated with functional-substance-containing thin film and process for producing the same

Country Status (2)

Country Link
JP (1) JP4553568B2 (en)
WO (1) WO2005033304A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007090324A (en) * 2005-09-05 2007-04-12 Tokuyama Corp Microreactor and manufacturing method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031689A1 (en) * 2007-07-06 2009-01-08 Evonik Goldschmidt Gmbh enzyme preparations
DE102010028788B4 (en) * 2010-05-10 2022-03-31 Tutech Innovation Gmbh A column installation that can be used in reactive rectification and has a biocatalyst and its use in reactive rectification
CN112805091A (en) * 2018-09-05 2021-05-14 齐姆特罗尼克斯催化系统股份有限公司 Enzyme and microsomes immobilized on magnetic scaffolds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003270230A (en) * 2002-03-15 2003-09-25 Asahi Kasei Corp Polymer immobilized element

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003270230A (en) * 2002-03-15 2003-09-25 Asahi Kasei Corp Polymer immobilized element

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
KATO D. ET AL: "Seitai System o Shusekika shita Soshi System no Kaihatsu", KAGAKU KOGYO, vol. 54, no. 5, May 2003 (2003-05-01), pages 339 - 345, XP002986423 *
KATO M. ET AL: "A protein-encapsulation technique by the sol-gel method for the oreparation of monolithic columns for capillary electrochromatography", ANAL. CHEM., vol. 74, no. 8, 2002, pages 1915 - 1921, XP002903432 *
KATO M. ET AL: "Effect of preparatory conditions on the performance of photopolymerized sol-gel moniliths for capillary electrochromatography", JOURNAL OF CHROMATOGRAPHY A, vol. 961, no. 1, 2002, pages 45 - 51, XP004369770 *
KATO M. ET AL: "Integration of on-line protein digestion, peptide separation, and protein identification using pepsin-coated photopolymerized sol-gel columns and capillary electrophoresis/mass spectrometry", ANAL. CHEM., vol. 76, no. 7, April 2004 (2004-04-01), pages 1896 - 1902, XP002903435 *
KATO M. ET AL: "Investigation of chromatographic performances and binding characteristics of BSA-encapsulated capillary column prepared by the sol-gel method", J.PHARM.BIOMED.ANAL., vol. 30, no. 6, January 2003 (2003-01-01), pages 1845 - 1850, XP002903433 *
KATO M. ET AL: "Photopolymerized sol-gel frits for packed columns in capillary electrochromatography", JOURNAL OF CHROMATOGRAPHY A, vol. 924, no. 1-2, 2001, pages 187 - 195, XP004273942 *
SAKAI K. ET AL: "Sol-gel-ho o Mochiita Tanpakushitsu Hogan Capillary Column ni yoru On-line Micro Reactor no Kaihatsu", DAI 22 KAI PROCEEDINGS OF THE SYMPOSIUM ON CAPILLARY ELECTROPHORESIS, THE JAPAN SOCIETY FOR ANALYTICAL CHEMISTRY HAKKO, 2002, pages 17 - 18, XP002986424 *
SAKAI-KATO K. ET AL: "Creation of an on-chip enzyme reactor by encapsulating trypsin in sol-gel on a plastic microchip", ANAL. CHEM., vol. 75, no. 3, February 2003 (2003-02-01), pages 388 - 393, XP001170890 *
SAKAI-KATO K. ET AL: "Investigation of structure and enantioselectivity of BSA-encapsulated sol-gel columns prepared for capillary electrochromatography", J. PHARM. BIOMED. ANAL., vol. 31, no. 2, February 2003 (2003-02-01), pages 299 - 309, XP002903431 *
SAKAI-KATO K. ET AL: "On-line drug-metabolism system using microsomes encapsulated in a capillary by the sol-gel method and integrated into capillary electrophoresis", ANAL. BIOCHEM., vol. 308, no. 2, 2002, pages 278 - 284, XP002903434 *
SAKAI-KATO K. ET AL: "On-line trypsinencapsulated enzyme reactor by the sol-gel method integrated into capillary electrophoresis", ANAL. CHEM., vol. 74, no. 13, 2002, pages 2943 - 2949, XP001132176 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007090324A (en) * 2005-09-05 2007-04-12 Tokuyama Corp Microreactor and manufacturing method thereof

Also Published As

Publication number Publication date
JP2005102574A (en) 2005-04-21
JP4553568B2 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
Li et al. Protein recognition via surface molecularly imprinted polymer nanowires
JP7562822B2 (en) Gel-Patterned Surfaces
AU2021212076B2 (en) Self-assembled patterning using patterned hydrophobic surfaces
Martin et al. Direct protein microarray fabrication using a hydrogel “stamper”
Piletsky Molecular imprinting of polymers
Qu et al. Stable microstructured network for protein patterning on a plastic microfluidic channel: strategy and characterization of on-chip enzyme microreactors
Kato et al. Silica sol‐gel monolithic materials and their use in a variety of applications
AU773289B2 (en) Biochannel assay for hybridization with biomaterial
Miyazaki et al. Microchannel enzyme reactors and their applications for processing
Brittain et al. The surface science of microarray generation–a critical inventory
EP1643249A1 (en) Bio-chip
CA2568960A1 (en) Functionalized porous carriers for microarrays
WO2019178033A1 (en) Ultrahigh throughput protein discovery
Timin et al. Immobilization of bovine serum albumin onto porous poly (vinylpyrrolidone)-modified silicas
JP5883386B2 (en) Protein or peptide printing method, protein array or peptide array production method, and functional protein or functional peptide identification method
JP7048510B2 (en) Electrochemical reactor for controlling PH with small dimensions
Pidenko et al. Proteins: templates and matrices in molecular imprinting
JP4553568B2 (en) Immobilization element coated with functional substance-containing thin film and method for producing the same
WO1999051770A1 (en) A method for the preparation of compound micro array chips and the compound micro array chips produced according to said method
Muguruma Plasma‐Polymerized Films for Biochip Design
CN105233889B (en) Preparation method of polynorepinephrine functionalized microfluidic chip and its chiral separation application
JP2008281381A (en) High-density microarray and manufacturing method thereof
KR101569891B1 (en) Sol-gel Chip using Porous Substrate for Entrapping Small Molecules and Screening Method of Small Molecules Specific Material Using thereof
Bhardwaj et al. Development of oligopeptide-based novel biosensor by solid-phase peptide synthesis on microchip
GR20150100398A (en) Plasma micro/nano-structured polymeric microfluidic device for purifying nucleic acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase